avpt20250930_10q.htm

0001777921

AvePoint, Inc.

false

--12-31

Q3

2025

0.0001

0.0001

1,000,000

1,000,000

212,588

212,588

194,071

194,071

19.50

15.21

1,319,130

0

0

12

http://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember

3

3

5

4

3

0

36,591,511

4

10

4

14.76

8.79

1,704

1,704

193,580

—

193,580

5,679

5,679

191,044

—

—

1

false

false

false

false

The other segment items category includes professional services, rent, software maintenance, travel, depreciation and amortization, certain overhead expense, and mark-to-market of earn-out shares liabilities and warrant liabilities.

Refer to “Note 11 — Warrant Liabilities” for further details.

Include long-term unbilled receivables. 

The fair value of mandatorily redeemable noncontrolling interest is based on discounted redemption value using risk-free rates offered for similar financing with the same remaining maturities.

Variable lease cost includes common area maintenance, property taxes, and fluctuations in rent due to a change in an index or rate.

Includes the current portion of operating lease liabilities of $7.6 million, which is reflected in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

The majority of certificates of deposit are foreign deposits.

During 2023, the Company extended a credit facility to LCP with a total commitment of up to $5.0 million and maturities of greater than twelve months (the “LCP Notes Receivable”). Refer to “Note 13 — Growth Equity Fund” for further details. The LCP Notes Receivable bear interest at an annual rate equal to 8%. As of  September 30, 2025 and December 31, 2024, the LCP Notes Receivable in the amounts of $0.0 million and $3.8 million, respectively, were included in other assets within the condensed consolidated balance sheets. Fair values are based on discounted future cash flows using current interest rates offered for similar notes to third parties with similar credit ratings for the same remaining maturities. The change of 1% of the current interest rate will change the fair value by $0.3 million. 

Gain on securities consist of interest income from amortization of the discount arising at acquisition of U.S. treasury bills.

Short-term lease expenses include rent expenses from leases of 12 months or less on the transition date or lease commencement.

0001777921
2025-01-01
2025-09-30

xbrli:shares

0001777921
2025-11-05

thunderdome:item

iso4217:USD

0001777921
2025-09-30

0001777921
2024-12-31

iso4217:USD
xbrli:shares

0001777921
avpt:SAASMember
2025-07-01
2025-09-30

0001777921
avpt:SAASMember
2024-07-01
2024-09-30

0001777921
avpt:SAASMember
2025-01-01
2025-09-30

0001777921
avpt:SAASMember
2024-01-01
2024-09-30

0001777921
avpt:TermedLicenseAndSupportMember
2025-07-01
2025-09-30

0001777921
avpt:TermedLicenseAndSupportMember
2024-07-01
2024-09-30

0001777921
avpt:TermedLicenseAndSupportMember
2025-01-01
2025-09-30

0001777921
avpt:TermedLicenseAndSupportMember
2024-01-01
2024-09-30

0001777921
us-gaap:ServiceMember
2025-07-01
2025-09-30

0001777921
us-gaap:ServiceMember
2024-07-01
2024-09-30

0001777921
us-gaap:ServiceMember
2025-01-01
2025-09-30

0001777921
us-gaap:ServiceMember
2024-01-01
2024-09-30

0001777921
us-gaap:MaintenanceMember
2025-07-01
2025-09-30

0001777921
us-gaap:MaintenanceMember
2024-07-01
2024-09-30

0001777921
us-gaap:MaintenanceMember
2025-01-01
2025-09-30

0001777921
us-gaap:MaintenanceMember
2024-01-01
2024-09-30

0001777921
2025-07-01
2025-09-30

0001777921
2024-07-01
2024-09-30

0001777921
2024-01-01
2024-09-30

0001777921
us-gaap:CommonStockMember
2025-06-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2025-06-30

0001777921
us-gaap:RetainedEarningsMember
2025-06-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30

0001777921
2025-06-30

0001777921
us-gaap:CommonStockMember
2025-07-01
2025-09-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2025-07-01
2025-09-30

0001777921
us-gaap:RetainedEarningsMember
2025-07-01
2025-09-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-07-01
2025-09-30

0001777921
us-gaap:CommonStockMember
2025-09-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2025-09-30

0001777921
us-gaap:RetainedEarningsMember
2025-09-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-30

0001777921
us-gaap:CommonStockMember
2024-06-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2024-06-30

0001777921
us-gaap:RetainedEarningsMember
2024-06-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30

0001777921
us-gaap:NoncontrollingInterestMember
2024-06-30

0001777921
2024-06-30

0001777921
us-gaap:CommonStockMember
2024-07-01
2024-09-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-30

0001777921
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-07-01
2024-09-30

0001777921
us-gaap:NoncontrollingInterestMember
2024-07-01
2024-09-30

0001777921
us-gaap:CommonStockMember
2024-09-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2024-09-30

0001777921
us-gaap:RetainedEarningsMember
2024-09-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-30

0001777921
us-gaap:NoncontrollingInterestMember
2024-09-30

0001777921
2024-09-30

0001777921
us-gaap:CommonStockMember
2024-12-31

0001777921
us-gaap:AdditionalPaidInCapitalMember
2024-12-31

0001777921
us-gaap:RetainedEarningsMember
2024-12-31

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31

0001777921
us-gaap:NoncontrollingInterestMember
2024-12-31

0001777921
us-gaap:CommonStockMember
2025-01-01
2025-09-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-09-30

0001777921
us-gaap:RetainedEarningsMember
2025-01-01
2025-09-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-09-30

0001777921
us-gaap:NoncontrollingInterestMember
2025-01-01
2025-09-30

0001777921
us-gaap:NoncontrollingInterestMember
2025-09-30

0001777921
us-gaap:NoncontrollingInterestMember
2023-12-31

0001777921
avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember
2023-12-31

0001777921
avpt:CommonStockOutstandingMember
2023-12-31

0001777921
us-gaap:CommonStockMember
2023-12-31

0001777921
us-gaap:AdditionalPaidInCapitalMember
2023-12-31

0001777921
us-gaap:RetainedEarningsMember
2023-12-31

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31

0001777921
2023-12-31

0001777921
avpt:CommonStockOutstandingMember
2024-01-01
2024-09-30

0001777921
us-gaap:CommonStockMember
2024-01-01
2024-09-30

0001777921
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-09-30

0001777921
us-gaap:RetainedEarningsMember
2024-01-01
2024-09-30

0001777921
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-09-30

0001777921
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-09-30

0001777921
avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember
2024-01-01
2024-09-30

0001777921
avpt:TemporaryEquityIncludingPortionAttributableToNoncontrollingInterestsMember
2024-09-30

0001777921
avpt:CommonStockOutstandingMember
2024-09-30

0001777921
avpt:SecondaryOfferingMember
2025-09-18

iso4217:SGD
xbrli:shares

0001777921
us-gaap:OverAllotmentOptionMember
2025-09-18

0001777921
us-gaap:SubsequentEventMember
us-gaap:OverAllotmentOptionMember
2025-10-24
2025-10-24

0001777921
avpt:SecondaryOfferingMember
2025-09-18
2025-09-18

0001777921
avpt:TermedLicenseAndSupportMember
us-gaap:TransferredAtPointInTimeMember
2025-07-01
2025-09-30

0001777921
avpt:TermedLicenseAndSupportMember
us-gaap:TransferredAtPointInTimeMember
2025-01-01
2025-09-30

0001777921
avpt:TermedLicenseAndSupportMember
us-gaap:TransferredAtPointInTimeMember
2024-07-01
2024-09-30

0001777921
avpt:TermedLicenseAndSupportMember
us-gaap:TransferredAtPointInTimeMember
2024-01-01
2024-09-30

0001777921
avpt:SAASMember
2025-09-30

xbrli:pure

0001777921
2025-10-01
2025-09-30

utr:M

0001777921
avpt:YdenticHoldingBvMember
2025-01-29

0001777921
avpt:YdenticHoldingBvMember
avpt:YdenticBVMember
2025-01-29

0001777921
avpt:YdenticHoldingBvMember
2025-01-29
2025-01-29

0001777921
avpt:YdenticHoldingBvMember
avpt:SharesSubjectToMandatoryRedemptionMember
2025-01-29
2025-01-29

0001777921
avpt:YdenticHoldingBvMember
2025-07-01
2025-09-30

0001777921
avpt:YdenticHoldingBvMember
2025-01-01
2025-09-30

0001777921
avpt:YdenticHoldingBvMember
2025-09-30

0001777921
avpt:YdenticHoldingBvMember
us-gaap:TechnologyBasedIntangibleAssetsMember
2025-01-01
2025-09-30

utr:Y

0001777921
avpt:YdenticHoldingBvMember
us-gaap:CustomerRelatedIntangibleAssetsMember
2025-01-01
2025-09-30

0001777921
avpt:YdenticHoldingBvMember
avpt:SharesSubjectToMandatoryRedemptionMember
2025-01-29

0001777921
avpt:YdenticHoldingBvMember
avpt:SharesSubjectToMandatoryRedemptionMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2025-01-29

0001777921
avpt:YdenticHoldingBvMember
avpt:SharesSubjectToMandatoryRedemptionMember
2025-09-30

0001777921
us-gaap:TechnologyBasedIntangibleAssetsMember
2025-09-30

0001777921
us-gaap:TechnologyBasedIntangibleAssetsMember
2024-12-31

0001777921
us-gaap:CustomerRelationshipsMember
2025-09-30

0001777921
us-gaap:CustomerRelationshipsMember
2024-12-31

0001777921
us-gaap:MediaContentMember
2025-09-30

0001777921
us-gaap:MediaContentMember
2024-12-31

0001777921
us-gaap:TradeAccountsReceivableMember
2025-09-30

0001777921
us-gaap:TradeAccountsReceivableMember
2024-12-31

0001777921
avpt:UnbilledReceivableMember
2025-09-30

0001777921
avpt:UnbilledReceivableMember
2024-12-31

0001777921
us-gaap:RevolvingCreditFacilityMember
avpt:HSBCVentureBankUsaIncMember
2023-11-03

0001777921
avpt:LineOfCreditAccordionFeatureMember
avpt:HSBCVentureBankUsaIncMember
2023-11-03

0001777921
2023-11-03
2023-11-03

0001777921
avpt:LineOfCreditAccordionFeatureMember
avpt:HSBCVentureBankUsaIncMember
srt:MinimumMember
2023-11-03
2023-11-03

0001777921
avpt:LineOfCreditAccordionFeatureMember
avpt:HSBCVentureBankUsaIncMember
srt:MaximumMember
2023-11-03
2023-11-03

0001777921
avpt:LineOfCreditAccordionFeatureMember
avpt:HSBCVentureBankUsaIncMember
2023-11-03
2023-11-03

0001777921
us-gaap:RevolvingCreditFacilityMember
avpt:HSBCVentureBankUsaIncMember
2025-09-30

0001777921
avpt:GuaranteeForServiceAgreementMember
2022-12-31

0001777921
avpt:ITSolutionsMember
2022-12-01
2022-12-31

0001777921
avpt:ITSolutionsMember
2025-07-01
2025-09-30

0001777921
avpt:ITSolutionsMember
2025-01-01
2025-09-30

0001777921
avpt:ITSolutionsMember
2024-07-01
2024-09-30

0001777921
avpt:ITSolutionsMember
2024-01-01
2024-09-30

0001777921
avpt:ITSolutionsMember
2024-12-31

0001777921
avpt:ITSolutionsMember
2024-12-01
2024-12-31

0001777921
avpt:GrowthEquityFundMember
2024-02-28

0001777921
avpt:ClassActionLawsuitMember
avpt:DefendantsMember
2024-02-02
2024-02-02

0001777921
avpt:ClassActionLawsuitMember
avpt:SponsorsMember
2024-02-02
2024-02-02

0001777921
avpt:ClassActionLawsuitMember
2024-01-01
2024-12-31

0001777921
avpt:ClassActionLawsuitMember
2024-10-01
2024-10-31

0001777921
avpt:AccruedExpenseAndOtherCurrentLiabilitiesMember
avpt:ClassActionLawsuitMember
2025-09-30

0001777921
avpt:AccruedExpenseAndOtherCurrentLiabilitiesMember
avpt:ClassActionLawsuitMember
2024-12-31

0001777921
avpt:GuaranteeForServiceAgreementMember
2025-09-30

0001777921
avpt:PrivatePlacementWarrantMember
2021-07-01

0001777921
2025-04-10
2025-04-10

0001777921
avpt:PrivatePlacementWarrantMember
2025-04-10

0001777921
avpt:PrivatePlacementWarrantMember
2024-12-31

0001777921
avpt:PrivatePlacementWarrantMember
2025-07-01
2025-09-30

0001777921
avpt:PrivatePlacementWarrantMember
2025-01-01
2025-09-30

0001777921
avpt:PrivatePlacementWarrantMember
2024-07-01
2024-09-30

0001777921
avpt:PrivatePlacementWarrantMember
2024-01-01
2024-09-30

0001777921
2022-03-17
2022-03-17

0001777921
2022-02-25

0001777921
avpt:PublicWarrantMember
2021-07-01

utr:D

0001777921
srt:MinimumMember
2025-06-06

0001777921
avpt:PublicWarrantMember
2025-06-06

0001777921
avpt:PublicWarrantMember
2025-07-16
2025-07-16

0001777921
avpt:PublicWarrantMember
2025-07-16

0001777921
avpt:PublicWarrantMember
2025-01-01
2025-09-30

0001777921
avpt:PublicWarrantMember
2025-09-30

0001777921
avpt:AvepointEdutechPteLtdMember
2025-05-30
2025-05-30

0001777921
avpt:AvepointEdutechPteLtdMember
2024-12-31

0001777921
avpt:A3VenturesFund1LpMember
2024-02-28
2024-02-28

0001777921
avpt:A3VenturesFund1LpMember
2024-02-28

0001777921
avpt:A3VenturesFund1LpMember
2025-01-01
2025-09-30

0001777921
avpt:A3VenturesFund1LpMember
2025-07-01
2025-09-30

0001777921
avpt:A3VenturesFund1LpMember
2024-07-01
2024-09-30

0001777921
avpt:A3VenturesFund1LpMember
2024-01-01
2024-09-30

0001777921
avpt:A3VenturesFund1LpMember
2025-09-30

0001777921
avpt:A3VenturesFund1LpMember
2024-12-31

0001777921
avpt:The2021PlanMember
2025-09-30

0001777921
avpt:The2021PlanMember
2025-07-01
2025-09-30

0001777921
avpt:The2021PlanMember
2025-01-01
2025-09-30

0001777921
avpt:The2021PlanMember
2024-07-01
2024-09-30

0001777921
avpt:The2021PlanMember
2024-01-01
2024-09-30

0001777921
us-gaap:EmployeeStockOptionMember
avpt:The2021PlanMember
2025-01-01
2025-09-30

0001777921
avpt:The2021PlanMember
2025-03-14
2025-03-14

0001777921
us-gaap:EmployeeStockOptionMember
avpt:The2021PlanMember
2025-03-14
2025-03-14

0001777921
us-gaap:RestrictedStockUnitsRSUMember
avpt:The2021PlanMember
2025-01-01
2025-09-30

0001777921
us-gaap:PerformanceSharesMember
avpt:The2021PlanMember
2025-01-01
2025-09-30

0001777921
us-gaap:RestrictedStockUnitsRSUMember
avpt:The2021PlanMember
2025-09-30

0001777921
us-gaap:PerformanceSharesMember
avpt:The2021PlanMember
2025-09-30

0001777921
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel1Member
2025-09-30

0001777921
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel2Member
2025-09-30

0001777921
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel3Member
2025-09-30

0001777921
us-gaap:CertificatesOfDepositMember
2025-09-30

0001777921
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
2025-09-30

0001777921
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2025-09-30

0001777921
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
2025-09-30

0001777921
us-gaap:MoneyMarketFundsMember
2025-09-30

0001777921
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-09-30

0001777921
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-09-30

0001777921
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-09-30

0001777921
us-gaap:USTreasurySecuritiesMember
2025-09-30

0001777921
us-gaap:FairValueInputsLevel1Member
2025-09-30

0001777921
us-gaap:FairValueInputsLevel2Member
2025-09-30

0001777921
us-gaap:FairValueInputsLevel3Member
2025-09-30

0001777921
us-gaap:FairValueInputsLevel1Member
avpt:UnconditionalPurchaseObligationMember
2025-09-30

0001777921
us-gaap:FairValueInputsLevel2Member
avpt:UnconditionalPurchaseObligationMember
2025-09-30

0001777921
us-gaap:FairValueInputsLevel3Member
avpt:UnconditionalPurchaseObligationMember
2025-09-30

0001777921
avpt:UnconditionalPurchaseObligationMember
2025-09-30

0001777921
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel1Member
2024-12-31

0001777921
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel2Member
2024-12-31

0001777921
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel3Member
2024-12-31

0001777921
us-gaap:CertificatesOfDepositMember
2024-12-31

0001777921
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
2024-12-31

0001777921
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2024-12-31

0001777921
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel3Member
2024-12-31

0001777921
us-gaap:MoneyMarketFundsMember
2024-12-31

0001777921
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel1Member
2024-12-31

0001777921
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel2Member
2024-12-31

0001777921
us-gaap:USTreasurySecuritiesMember
us-gaap:FairValueInputsLevel3Member
2024-12-31

0001777921
us-gaap:USTreasurySecuritiesMember
2024-12-31

0001777921
us-gaap:NotesReceivableMember
us-gaap:FairValueInputsLevel1Member
2024-12-31

0001777921
us-gaap:NotesReceivableMember
us-gaap:FairValueInputsLevel2Member
2024-12-31

0001777921
us-gaap:NotesReceivableMember
us-gaap:FairValueInputsLevel3Member
2024-12-31

0001777921
us-gaap:NotesReceivableMember
2024-12-31

0001777921
us-gaap:FairValueInputsLevel1Member
2024-12-31

0001777921
us-gaap:FairValueInputsLevel2Member
2024-12-31

0001777921
us-gaap:FairValueInputsLevel3Member
2024-12-31

0001777921
us-gaap:FairValueInputsLevel1Member
avpt:WarrantLiabilitiesMember
2024-12-31

0001777921
us-gaap:FairValueInputsLevel2Member
avpt:WarrantLiabilitiesMember
2024-12-31

0001777921
us-gaap:FairValueInputsLevel3Member
avpt:WarrantLiabilitiesMember
2024-12-31

0001777921
avpt:WarrantLiabilitiesMember
2024-12-31

0001777921
avpt:LumensCapitalPartnersLtdTheLcpMember
2023-12-31

0001777921
avpt:LumensCapitalPartnersLtdTheLcpMember
2024-12-31

0001777921
us-gaap:USTreasurySecuritiesMember
2025-09-30

0001777921
us-gaap:USTreasurySecuritiesMember
2024-12-31

0001777921
srt:NorthAmericaMember
2025-07-01
2025-09-30

0001777921
srt:NorthAmericaMember
2024-07-01
2024-09-30

0001777921
srt:NorthAmericaMember
2025-01-01
2025-09-30

0001777921
srt:NorthAmericaMember
2024-01-01
2024-09-30

0001777921
us-gaap:EMEAMember
2025-07-01
2025-09-30

0001777921
us-gaap:EMEAMember
2024-07-01
2024-09-30

0001777921
us-gaap:EMEAMember
2025-01-01
2025-09-30

0001777921
us-gaap:EMEAMember
2024-01-01
2024-09-30

0001777921
srt:AsiaPacificMember
2025-07-01
2025-09-30

0001777921
srt:AsiaPacificMember
2024-07-01
2024-09-30

0001777921
srt:AsiaPacificMember
2025-01-01
2025-09-30

0001777921
srt:AsiaPacificMember
2024-01-01
2024-09-30

0001777921
country:US
2025-07-01
2025-09-30

0001777921
country:US
2024-07-01
2024-09-30

0001777921
country:US
2025-01-01
2025-09-30

0001777921
country:US
2024-01-01
2024-09-30

0001777921
country:DE
2025-07-01
2025-09-30

0001777921
country:DE
2024-07-01
2024-09-30

0001777921
country:DE
2025-01-01
2025-09-30

0001777921
country:DE
2024-01-01
2024-09-30

0001777921
country:SG
2025-07-01
2025-09-30

0001777921
country:SG
2024-07-01
2024-09-30

0001777921
country:SG
2025-01-01
2025-09-30

0001777921
country:SG
2024-01-01
2024-09-30

0001777921
us-gaap:EmployeeStockOptionMember
2025-07-01
2025-09-30

0001777921
us-gaap:EmployeeStockOptionMember
2024-07-01
2024-09-30

0001777921
us-gaap:EmployeeStockOptionMember
2025-01-01
2025-09-30

0001777921
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-09-30

0001777921
us-gaap:RestrictedStockUnitsRSUMember
2025-07-01
2025-09-30

0001777921
us-gaap:RestrictedStockUnitsRSUMember
2024-07-01
2024-09-30

0001777921
us-gaap:RestrictedStockUnitsRSUMember
2025-01-01
2025-09-30

0001777921
us-gaap:RestrictedStockUnitsRSUMember
2024-01-01
2024-09-30

0001777921
us-gaap:WarrantMember
2025-07-01
2025-09-30

0001777921
us-gaap:WarrantMember
2024-07-01
2024-09-30

0001777921
us-gaap:WarrantMember
2025-01-01
2025-09-30

0001777921
us-gaap:WarrantMember
2024-01-01
2024-09-30

0001777921
avpt:CompanyEarnOutsMember
2025-07-01
2025-09-30

0001777921
avpt:CompanyEarnOutsMember
2024-07-01
2024-09-30

0001777921
avpt:CompanyEarnOutsMember
2025-01-01
2025-09-30

0001777921
avpt:CompanyEarnOutsMember
2024-01-01
2024-09-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended 
September 30, 2025

or

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to ___________.

Commission file number: 
001-39048

AvePoint, Inc.

(Exact name of registrant as specified in its charter)

Delaware

83-4461709

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

525 Washington Blvd, Suite 1400

Jersey City
, 
NJ

07310

(Address of principal executive offices) (Zip Code)

(
804
) 
314-5903

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

AVPT

The 
Nasdaq
 Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes
 ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes
 ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
 ☒

Accelerated filer ☐

Non-accelerated filer ☐
Smaller reporting company 
☐

Emerging growth company 
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes 
☐
 No ☒

As of November 5, 2025, there were 
215,789,313
 shares of the registrant’s common stock, par value $0.0001 per share, issued and outstanding.

Table of Contents

AVEPOINT, INC.

FORM 10-Q

For the Fiscal Quarter Ended

September 30, 2025

TABLE OF CONTENTS

Page

FORWARD-LOOKING STATEMENTS

3

PART I. FINANCIAL INFORMATION

4

Item 1. Financial Statements

4

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

31

Item 3. Quantitative and Qualitative Disclosures About Market Risk

48

Item 4. Controls and Procedures

49

PART II. 
OTHER INFORMATION

50

Item 1. Legal Proceedings

50

Item 1A. Risk Factors

50

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

51

Item 3.

Defaults Upon Senior Securities

51

Item 4.

Mine Safety Disclosures

51

Item 5.

Other Information

52

Item 6. Exhibits

53

Signatures

54

        2

Table of Contents

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “
Quarterly Report
”) of AvePoint, Inc. (hereinafter referred to as the “
Company
,” “
AvePoint
,” “
we
," “
us
” and “
our
”) includes estimates, projections, statements relating to our business plans, objectives, and expected operating results that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “
Securities Act
”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “
Exchange Act
”). Forward-looking statements, as well as descriptions of the risks and uncertainties that could cause actual results and events to differ materially, may appear throughout this Quarterly Report, including in the following sections: “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (Part I, Item 2 of this Quarterly Report), “Quantitative and Qualitative Disclosures about Market Risk” (Part I, Item 3 of this Quarterly Report), and “Risk Factors” (Part II, Item 1A of this Quarterly Report). These risks and uncertainties also include, but are not limited to, those described from time to time in the Company’s reports filed with the Securities and Exchange Commission (“
SEC
”).

These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events, or developments that we expect or anticipate will occur in the future — including statements relating to volume growth, sales, earnings, and statements expressing general views about future operating results — are forward-looking statements. These forward-looking statements are, by their nature, subject to significant risks and uncertainties, and are based on the beliefs of, as well as assumptions made by and information currently available to, our management. Our management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Readers should evaluate all forward-looking statements made in the context of these risks and uncertainties. The important factors referenced above may not contain all of the factors that are important to investors.

In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law. All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by these cautionary statements as well as other cautionary statements that are made from time to time in our other SEC filings and public communications.

       3

Table of Contents

PART I

Item 1

PART I. FINANCIAL INFORMATION.

Item 1. Financial Statements.

Index to Financial Statements (Unaudited)

Page

Condensed Consolidated Balance Sheets 
as of September 30, 2025 and December 31, 2024

5

Condensed Consolidated Statements of Income (Loss) 
for the Three and Nine Months Ended September 30, 2025 and 2024

6

Condensed Consolidated Statements of Comprehensive Income (Loss) 
for the Three and Nine Months Ended September 30, 2025 and 2024

7

Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity 
for the Three and Nine Months Ended September 30, 2025 and 2024

8

Condensed Consolidated Statements of Cash Flows 
for the Nine Months Ended September 30, 2025 and 2024

10

Notes to Condensed Consolidated Financial Statements

11

       4

Table of Contents

AvePoint, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except par value)

(Unaudited)

September 30,

December 31,

2025

2024

Assets

Current assets:

Cash and cash equivalents

$
471,640

$
290,735

Accounts receivable, net

90,884

87,365

Prepaid expenses and other current assets

18,169

16,695

Total current assets

580,693

394,795

Property and equipment, net

6,140

5,289

Goodwill

37,908

17,715

Intangible assets, net

12,349

8,889

Operating lease right-of-use assets

18,380

15,954

Deferred contract costs

65,304

59,838

Other assets

22,741

16,575

Total assets

$
743,515

$
519,055

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$
2,519

$
2,352

Accrued expenses and other current liabilities

83,200

76,135

Current portion of deferred revenue

159,136

144,468

Total current liabilities

244,855

222,955

Long-term operating lease liabilities

11,344

9,909

Long-term portion of deferred revenue

15,066

8,840

Other liabilities

5,441

6,403

Total liabilities

276,706

248,107

Commitments and contingencies (Note 10)

Stockholders’ equity

Common stock, $
0.0001
 par value; 
1,000,000
 shares authorized, 
212,588
 and 
194,071
 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

21

19

Additional paid-in capital

970,918

779,007

Accumulated other comprehensive income

6,744

576

Accumulated deficit

(
510,874
)

(
510,448
)

Noncontrolling interest

—

1,794

Total stockholders’ equity

466,809

270,948

Total liabilities and stockholders’ equity

$
743,515

$
519,055

See accompanying notes.

     5

Table of Contents

AvePoint, Inc.

Condensed Consolidated Statements of Income (Loss)

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2025

2024

2025

2024

Revenue:

SaaS

$

83,982

$

60,866

$

230,241

$

165,820

Term license and support

11,143

14,140

31,255

35,128

Services

13,766

10,810

39,189

31,808

Maintenance

837

2,988

4,125

8,543

Total revenue

109,728

88,804

304,810

241,299

Cost of revenue:

SaaS

14,596

10,624

41,156

30,139

Term license and support

278

373

1,074

1,202

Services

13,255

10,057

35,973

28,777

Maintenance

16

167

320

487

Total cost of revenue

28,145

21,221

78,523

60,605

Gross profit

81,583

67,583

226,287

180,694

Operating expenses:

Sales and marketing

35,593

30,050

105,888

90,459

General and administrative

23,925

17,043

62,304

52,095

Research and development

13,936

12,838

39,585

35,827

Total operating expenses

73,454

59,931

207,777

178,381

Income from operations

8,129

7,652

18,510

2,313

Other income (expense), net

4,678

(
4,541

)

6,024

(
8,107

)

Income (loss) before income taxes

12,807

3,111

24,534

(
5,794

)

Income tax (benefit) expense

(
210

)

183

5,058

6,170

Net income (loss)

$

13,017

$

2,928

$

19,476

$

(
11,964

)

Net income (loss) attributable to noncontrolling interest

—

308

321

(
59

)

Net income (loss) available to common stockholders

$

13,017

$

2,620

$

19,155

$

(
11,905

)

Net income (loss) per share:

Basic

$

0.06

$

0.01

$

0.09

$

(
0.07

)

Diluted

$

0.06

$

0.01

$

0.08

$

(
0.07

)

Weighted average shares outstanding:

Basic

212,001

183,946

205,049

182,753

Diluted

232,897

203,859

228,985

182,753

See accompanying notes. 

     6

Table of Contents

AvePoint, Inc.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2025

2024

2025

2024

Net income (loss)

$

13,017

$

2,928

$

19,476

$

(
11,964

)

Other comprehensive income (loss) net of taxes

Unrealized gain (loss) on available-for-sale securities

45

3

28

(
138

)

Foreign currency translation adjustments

(
916

)

1,794

6,215

1,395

Total other comprehensive (loss) income

(
871

)

1,797

6,243

1,257

Total comprehensive income (loss)

$

12,146

$

4,725

$

25,719

$

(
10,707

)

Comprehensive income (loss) attributable to noncontrolling interest

—

406

432

(
35

)

Total comprehensive income (loss) available to common stockholders

$

12,146

$

4,319

$

25,287

$

(
10,672

)

See accompanying notes. 

     7

Table of Contents

AvePoint, Inc.

Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity

(In thousands, except share amounts)

(Unaudited)

Three Months Ended September 30, 2025

Accumulated

Additional

Other

Total

Common Stock

Paid-In

Accumulated

Comprehensive

Stockholders’

Shares

Amount

Capital

Deficit

Income

Equity

Balance, June 30, 2025

211,138,994

$

21

$

953,446

$

(
517,947

)

$

7,615

$

443,135

Proceeds from exercise of options

183,478

—

490

—

—

490

Common stock issued upon vesting of restricted stock units

1,035,332

—

—

—

—

—

Stock-based compensation expense

—

—

10,678

—

—

10,678

Proceeds from exercise of warrants

758,100

—

8,718

—

—

8,718

Redemption of warrants

—

—

(
2

)

—

—

(
2

)

Repurchase and retirement of common stock

(
528,132

)

—

(
2,412

)

(
5,944

)

—

(
8,356

)

Comprehensive income:

Net income

—

—

—

13,017

—

13,017

Unrealized gain on available-for-sale securities

—

—

—

—

45

45

Foreign currency translation adjustments

—

—

—

—

(
916

)

(
916

)

Balance, September 30, 2025

212,587,772

$

21

$

970,918

$

(
510,874

)

$

6,744

$

466,809

Three Months Ended September 30, 2024

Accumulated

Additional

Other

Total

Common Stock

Paid-In

Accumulated

Comprehensive

Noncontrolling

Stockholders’

Shares

Amount

Capital

Deficit

Income

Interest

Equity

Balance, June 30, 2024

186,657,306

$

19

$

688,487

$

(
485,327

)

$

2,732

$

1,497

$

207,408

Proceeds from exercise of options

117,457

—

279

—

—

—

279

Common stock issued upon vesting of restricted stock units

874,326

—

—

—

—

—

—

Stock-based compensation expense

—

—

9,811

—

—

—

9,811

Reclassification of earn-out RSUs to earn-out shares

—

—

(
120

)

—

—

—

(
120

)

Purchase of public warrants

—

—

(
3,828

)

—

—

—

(
3,828

)

Repurchase and retirement of common stock

(
218,546

)

—

(
810

)

(
1,744

)

—

—

(
2,554

)

Comprehensive loss:

Net income

—

—

—

2,620

—

308

2,928

Unrealized gain on available-for-sale securities

—

—

—

—

3

—

3

Foreign currency translation adjustments

—

—

—

—

1,696

98

1,794

Balance, September 30, 2024

187,430,543

$

19

$

693,819

$

(
484,451

)

$

4,431

$

1,903

$

215,721

See accompanying notes. 

       8

AvePoint, Inc.

Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity

(In thousands, except share amounts)

(Unaudited)

Nine Months Ended September 30, 2025

Accumulated

Additional

Other

Total

Common Stock

Paid-In

Accumulated

Comprehensive

Noncontrolling

Stockholders’

Shares

Amount

Capital

Deficit

Income

Interest

Equity

Balance, December 31, 2024

194,070,512

$

19

$

779,007

$

(
510,448

)

$

576

$

1,794

$

270,948

Proceeds from exercise of options

1,679,075

—

8,519

—

—

—

8,519

Common stock issued upon vesting of restricted stock units

3,956,586

—

—

—

—

—

—

Stock-based compensation expense

—

—

31,441

—

—

—

31,441

Repurchase of noncontrolling interest

—

—

(
9,958

)

—

36

(
2,226

)

(
12,148

)

Reclassification of warrant liabilities

—

—

1,452

—

—

—

1,452

Proceeds from exercise of warrants

14,625,054

2

168,187

—

—

—

168,189

Redemption of warrants

—

—

(
2

)

(
2

)

Repurchase and retirement of common stock

(
1,743,455

)

—

(
7,728

)

(
19,581

)

—

—

(
27,309

)

Comprehensive income:

Net income

—

—

—

19,155

—

321

19,476

Unrealized gain on available-for-sale securities

—

—

—

—

28

—

28

Foreign currency translation adjustments

—

—

—

—

6,104

111

6,215

Balance, September 30, 2025

212,587,772

$

21

$

970,918

$

(
510,874

)

$

6,744

$

—

$

466,809

Nine Months Ended September 30, 2024

Redeemable

Total

Accumulated

noncontrolling

mezzanine

Additional

Other

Total

interest

equity

Common Stock

Paid-In

Accumulated

Comprehensive

Noncontrolling

Stockholders’

Amount

Amount

Shares

Amount

Capital

Deficit

Income

Interest

Equity

Balance, December 31, 2023

$

6,038

$

6,038

184,652,402

$

18

$

667,881

$

(
460,496

)

$

3,196

$

8,207

$

218,806

Proceeds from exercise of options

—

—

1,502,820

—

3,613

—

—

—

3,613

Common stock issued upon vesting of restricted stock units

—

—

3,905,299

1

(
1

)

—

—

—

—

Stock-based compensation expense

—

—

—

—

29,807

—

—

—

29,807

Accretion of redeemable noncontrolling interest

(
99

)

(
99

)

—

—

—

99

—

—

99

Redemption of noncontrolling interest

(
5,926

)

(
5,926

)

—

—

6,379

—

2

(
6,381

)

—

Reclassification of earn-out RSUs to earn-out shares

—

—

—

—

(
378

)

—

—

—

(
378

)

Purchase of public warrants

—

—

—

—

(
3,828

)

—

—

—

(
3,828

)

Repurchase and retirement of common stock

—

—

(
2,629,978

)

—

(
9,654

)

(
12,050

)

—

—

(
21,704

)

Comprehensive (loss) income:

Net (loss) income

(
5

)

(
5

)

—

—

—

(
12,004

)

—

45

(
11,959

)

Unrealized loss on available-for-sale securities

—

—

—

—

—

—

(
138

)

—

(
138

)

Foreign currency translation adjustments

(
8

)

(
8

)

—

—

—

—

1,371

32

1,403

Balance, September 30, 2024

$

—

$

—

187,430,543

$

19

$

693,819

$

(
484,451

)

$

4,431

$

1,903

$

215,721

See accompanying notes. 

     9

Table of Contents

AvePoint, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Nine Months Ended

September 30,

2025

2024

Operating activities

Net income (loss)

$

19,476

$

(
11,964

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation and amortization

4,642

4,020

Operating lease right-of-use assets expense

6,400

4,975

Foreign currency remeasurement loss

4,302

1,212

Stock-based compensation

31,441

29,807

Deferred income taxes

(
3,617

)

(
235

)

Allowance for credit loss on notes receivables

4,037

—

Other

78

(
4

)

Change in value of earn-out and warrant liabilities

(
408

)

11,717

Changes in operating assets and liabilities:

Accounts receivable

2,210

6,873

Prepaid expenses and other current assets

(
972

)

1,767

Deferred contract costs and other assets

(
8,616

)

(
3,280

)

Accounts payable, accrued expenses, other current liabilities, operating lease liabilities and other liabilities

(
16,167

)

(
598

)

Deferred revenue

12,792

11,844

Net cash provided by operating activities

55,598

56,134

Investing activities

Maturities of investments

140

5,361

Purchases of investments

(
140

)

(
1,850

)

Repurchase of noncontrolling interest

(
12,148

)

—

Capitalization of internal-use software

(
1,162

)

(
947

)

Purchase of property and equipment

(
2,986

)

(
2,303

)

Issuance of notes receivables

—

(
1,500

)

Cash paid in business combinations, net of cash acquired

(
14,893

)

—

Other investing activities

—

(
130

)

Net cash used in investing activities

(
31,189

)

(
1,369

)

Financing activities

Purchase of common stock

(
27,309

)

(
21,704

)

Proceeds from warrant exercises

168,189

—

Proceeds from stock option exercises

8,519

3,613

Funds held on behalf of others

6,064

—

Redemption of redeemable noncontrolling interest

—

(
6,130

)

Purchase of public warrants

—

(
3,991

)

Repayments of finance leases

(
5

)

(
6

)

Redemption of warrants

(
2

)

—

Net cash provided by (used in) financing activities

155,456

(
28,218

)

Effect of exchange rates on cash

1,040

94

Net increase in cash and cash equivalents

180,905

26,641

Cash and cash equivalents at beginning of period

290,735

223,162

Cash and cash equivalents at end of period

$

471,640

$

249,803

Supplemental disclosures of cash flow information

Income taxes paid

$

4,700

$

5,552

Unpaid purchase consideration transferred in connection with the business combination

$

5,499

$

—

See accompanying notes.

     10

Table of Contents

       AvePoint, Inc.

       Notes to Condensed Consolidated Financial Statements

       (Unaudited)

1.
 Nature of Business and Organization 

AvePoint, Inc. (collectively with its subsidiaries, hereinafter referred to as “
AvePoint
,” the “
Company
,” “
we
,” “
us
,” or “
our
”) was incorporated as a New Jersey corporation on 
 July 24, 2001 
and redomiciled as a Delaware corporation in 
2006.

Our principal executive headquarters is located in Jersey City, New Jersey, and our principal operating headquarters is located in Richmond, Virginia. We have additional offices in North America, Europe, Asia, Australia and the Middle East.

AvePoint generates revenue by providing customers a cloud-native data management software platform (the “
AvePoint Confidence Platform
”), enabling them to prepare, secure, and optimize their critical data. The AvePoint Confidence Platform unifies data security, governance, and business continuity into a seamless, resilient experience, addressing the most pressing challenges in today’s complex digital landscape.

AvePoint’s common stock is listed on The Nasdaq Global Select Market (“
Nasdaq
”) under the symbol “AVPT”. On 
 September 18, 2025, 
AvePoint completed a secondary listing of its common stock on the Main Board of Singapore Exchange Securities Trading Limited (the “
SGX-ST
”) under the symbol “AVP”, in connection with a secondary offering of 
13,290,360
 shares of its common stock at the public offering price of 
S$19.50
 per share, or approximately 
US$15.21
 per share. The shares listed on the SGX-ST are fully fungible with the shares listed on Nasdaq. The underwriters of the secondary offering were granted an over-allotment option to purchase up to an additional 
1,993,550
 shares of common stock at the public offering price. On 
 October 24, 2025, 
the underwriters partially executed the over-allotment option for an additional 
1,319,130
 shares of common stock. AvePoint did 
not
 receive any proceeds from the sale of its shares in the secondary offering of its common stock on the SGX-ST.

2.
 Summary of Significant Accounting Policies 

Basis of Presentation 

The accompanying unaudited condensed consolidated balance sheet as of 
 December 31, 2024, 
which has been derived from audited financial statements, and the unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “
SEC
”)﻿ for interim financial information and include the accounts of the Company and entities consolidated under the variable interest and voting models. All intercompany transactions and balances have been eliminated. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the U.S. (“
GAAP
”) have been condensed or omitted.

In the opinion of management, these financial statements contain all material adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position, results of operations and cash flows for the periods indicated. Operating results for the 
nine
 months ended 
 September 30, 2025
 are 
not
 necessarily indicative of the results that 
 may 
be expected for any other interim period or for the year ended 
 December 31, 2025.

These condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the related notes included in our most recent Annual Report on Form 
10
-K for the year ended 
 December 31, 2024
, which was filed with the SEC on 
 February 27, 2025 (“
Annual Report
”).

11

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. We base our estimates and assumptions on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The amounts of assets and liabilities reported and the amounts of revenue and expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but 
not
 limited to, the accounting for the determination of standalone selling price for revenue recognition, deferred contract costs, valuation of goodwill and other intangible assets, income taxes and related reserves, stock-based compensation and purchase price in a business combination. Actual results and outcomes 
 may 
differ from management’s estimates and assumptions due to risks and uncertainties. 

Comparative Data

Certain amounts from prior periods have been reclassed to conform to the current period presentation, including: 

•
The reclassification of short-term investments to be included in prepaid expenses and other current assets on the condensed consolidated balance sheets as of 
 December 31, 2024. 

Cash and Cash Equivalents 

The Company maintains cash and cash equivalents with several high credit-quality financial institutions. The Company considers its investments with original maturities of 
three
 months or less to be cash equivalents. These investments are 
not
 subject to significant market risk. The Company maintains its cash and cash equivalents in bank accounts which, at times, exceed the federally insured limits. The Company has 
not
 experienced any losses in such accounts. The Company maintains cash balances used in operations at entities based in countries that impose regulations that limit the ability to transfer cash out of the country. As of 
 September 30, 2025
 and 
 December 31, 2024
, the Company’s cash balances at these entities were $
15.3
 million and $
15.5
 million, respectively. For purposes of the condensed consolidated statements of cash flows, cash includes all amounts in the condensed consolidated balance sheets captioned cash and cash equivalents.

Business Combination

When we consummate a business combination, the assets acquired, and the liabilities assumed are recognized separately from goodwill at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of the fair value of consideration transferred over the acquisition date fair value of the net identifiable assets acquired. While best estimates and assumptions are used to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which 
 may 
be up to 
one
 year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill as we obtain new information about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. Upon the earlier of the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, any subsequent adjustments are recorded in the condensed consolidated statements of income (loss).

12

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

Goodwill

No
 events or circumstances have changed since any of our acquisitions that would indicate that the fair value of our reporting unit is below its carrying amount. 
No
 impairment was deemed necessary as of 
 September 30, 2025
 or 
 December 31, 2024
.

Deferred Contract Costs 

We defer sales commissions that are considered to be incremental and recoverable costs of obtaining or renewing SaaS, term license and support, services, and maintenance contracts. Changes in the anticipated period of asset benefit or the average renewal term are recognized on a prospective basis upon occurrence. 

Amortization of deferred contract costs of $
5.7
 million and $
16.7
 million for the 
three
 and 
nine
 months ended 
 September 30, 2025
, respectively, and $
5.6
 million and $
15.7
 million for the 
three
 and 
nine
 months ended 
 September 30, 2024
, respectively, is included as a component of sales and marketing expenses in our condensed consolidated statements of income (loss). Deferred contract costs recognized as a contract asset in the condensed consolidated balance sheets were $
65.3
 million and $
59.8
 million as of 
 September 30, 2025
 and 
 December 31, 2024
, respectively.

Revenue Recognition 

The Company derives revenue from 
four
 primary sources: SaaS, term license and support, services, and maintenance. Services include installation services, training and other consulting services.

Term license revenue recognized at a point in time was $
7.5
 million and $
19.7
 million for the 
three
 and 
nine
 months ended 
 September 30, 2025
, respectively, and $
9.9
 million and $
22.1
 million for the 
three
 and 
nine
 months ended 
 September 30, 2024
, respectively.

Accounts receivable, net is inclusive of accounts receivable, and current unbilled receivables, net of allowance for credit losses. We record an unbilled receivable when revenue is recognized prior to invoicing. We have a well-established collection history from our direct and indirect sales. We periodically evaluate the collectability of our accounts receivable and provide an allowance for credit losses as necessary, based on the age of the receivable, expected payment ability, and collection experience.

We record deferred revenue in the condensed consolidated balance sheets when cash is collected or invoiced before revenue is earned. Deferred revenue as of 
 September 30, 2025
 and 
 December 31, 2024
 was $
174.2
 million and $
153.3
 million, respectively. Revenue recognized that was included in the deferred revenue balance at the beginning of the period was $
131.1
 million for the 
nine
 months ended 
 September 30, 2025
.

13

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

The opening and closing balances of the Company’s accounts receivable, net, deferred revenue and deferred contract costs are as follows:

Accounts

Deferred

receivable,

Deferred

contract

net 
(1)

revenue

costs

(in thousands)

Balance, December 31, 2024

$
95,683

$
153,308

$
59,838

Balance, September 30, 2025

103,393

174,202

65,304

(
1
)
 Includes long-term unbilled receivables included in other assets within the condensed consolidated balance sheets.  

There were 
no
 significant changes to the Company’s contract assets or liabilities during the 
nine
 months ended 
 September 30, 2025
 and the year ended 
 December 31, 2024
 outside of its sales activities.

As of 
 September 30, 2025
, transaction price allocated to remaining performance obligations, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods, was $
475.2
 million, of which $
399.6
 million is related to SaaS and term license and support revenue. We expect to recognize approximately 
57
% of the total transaction price allocated to remaining performance obligations over the next 
twelve
 months and the remainder thereafter.

Stock-Based Compensation

Stock-based compensation represents the cost related to stock-based awards granted to employees. To date, we have issued both stock options and restricted stock units. The Company measures stock-based compensation cost at the grant date based on the estimated fair value of the award and recognizes the cost ratably over the requisite service period, net of actual forfeitures in the period.

We estimate the fair value of stock options using the Black-Scholes valuation model. The Black-Scholes model requires highly subjective assumptions in order to derive the inputs necessary to calculate the fair value of stock options. The Company calculates the expected term using the “simplified” method, which is the simple average of the vesting period and the contractual term. The simplified method is applied as the Company does 
not
 have sufficient historical data to provide a reasonable basis for an estimate of the expected term. Expected volatility is based on the historical volatility of a group of peer entities. Dividend yields are based upon historical dividend yields. Risk-free interest rates are based on the implied yields currently available on U.S. Treasury 
zero
 coupon issues with a remaining term equal to the expected term.

Recent Accounting Pronouncements 
Not
 Yet Effective

In 
 December 2023, 
the Financial Accounting Standards Board (the “
FASB
”) issued ASU 
No.

2023
-
09,
 “Improvements to Income Tax Disclosures (Topic 
740
)” (“
ASU 
2023
-
09
”). ASU 
2023
-
09
 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The amendment in this ASU is effective on a prospective basis for annual periods beginning after 
 December 15, 2024. 
Early adoption is also permitted. We are currently evaluating the impact ASU 
2023
-
09
 will have on our consolidated financial statements and related disclosures.

In 
 November 2024, 
the FASB issued ASU 
No.

2024
-
03,
 “Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (ASC 
220
-
40
): Disaggregation of Income Statement Expenses” (“
ASU

2024
-
03
”), and in 
 January 2025, 
the FASB issued ASU 
No.

2025
-
01,
 “Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (ASC 
220
-
40
): Clarifying the Effective Date” (“
ASU

2025
-
01
”). ASU 
2024
-
03
 requires public entities to disclose additional information about specific expense categories in the notes to the financial statements. ASU 
2024
-
03,
 as clarified by ASU 
2025
-
01,
 is effective in annual reporting periods beginning after 
 December 15, 2026, 
and interim periods within annual reporting periods beginning after 
 December 15, 2027
.
 The amendments in this ASU 
 may 
be applied either prospectively or retrospectively. Early adoption is also permitted. We are currently evaluating the impact ASU 
2024
-
03
 will have on our consolidated financial statements and related disclosures.

In 
 July 2025, 
the FASB issued ASU 
No.

2025
-
05,
 “Financial Instruments - Credit Losses (Topic 
326
): Measurement of Credit Losses for Accounts Receivable and Contract Assets” (“
ASU 
2025
-
05
”). ASU 
2025
-
05
 introduces a practical expedient to calculating current expected credit loss by assuming that the current conditions as of the balance sheet date will 
not
 change for the remaining life of the asset. This expedient can only be applied to current accounts receivable and current contract assets. ASU 
2025
-
05
 is effective on a prospective basis in annual reporting periods beginning after 
 December 15, 2025, 
and interim periods within those annual periods. Early adoption is also permitted. We are currently evaluating the impact ASU 
2025
-
05
 will have on our consolidated financial statements and related disclosures. The Company does 
not
 expect adoption of ASU 
2025
-
05
 to have a material impact on its consolidated financial statements. 

In 
 September 2025, 
the FASB issued ASU 
No.

2025
-
06,
 “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 
350
-
40
): Targeted Improvements to the Accounting for Internal-Use Software” (“
ASU 
2025
-
06
”). ASU 
2025
-
06
 modernizes the capitalization criteria for internal-use software, eliminating references to project stages and instead requiring that projects meet completion probability criteria before costs can be capitalized. This ASU 
2025
-
06
 is effective for annual periods beginning after 
 December 15, 2027, 
and interim periods within those annual periods. The amendments in this ASU 
 may 
be applied using a prospective, retrospective, or modified transition approach. Early adoption is also permitted. We are currently evaluating the impact ASU 
2025
-
06
 will have on our consolidated financial statements and related disclosures. 

14

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

3.
 Business Combination

Ydentic Acquisition

On 
 January 29, 2025, 
the Company consummated its acquisition of 
80
% of the outstanding shares of Ydentic Holding B.V., which owns 
100
% of the outstanding equity interests of Ydentic B.V. (together, “
Ydentic
”). The acquisition was made pursuant to the Share Purchase Agreement, by and among the Company and the former Ydentic shareholders. The Company completed the acquisition of Ydentic to further expand its SaaS solutions for providing robust, simple, centralized multi-tenant management for managed service providers (“
MSPs
”) that utilize Microsoft solutions. The estimated fair value of the transaction consideration is approximately $
20.4
 million, consisting of $
14.9
 million in cash paid at closing and a $
5.5
 million unconditional purchase obligation with variability in the timing and amount of settlement.

The acquisition-related costs incurred by the Company totaled $
1.3
 million, of which $
0.0
 million and $
0.5
 million were incurred during the 
three
 and 
nine
 months ended 
 September 30, 2025
, respectively. These costs are recognized as an expense in the general and administrative item in the condensed consolidated statements of income (loss).

The financial results of Ydentic have been included in our condensed consolidated financial statements since the date of the acquisition. The Company established a deferred tax liability with an offset to goodwill in connection with the accounting for the opening balance sheet of the Ydentic acquisition as a result of book-to-tax differences primarily related to the technology and software intangibles and customer related assets.

The valuation of assets acquired and liabilities assumed has 
not
 yet been finalized as of 
 September 30, 2025
.
 The purchase price allocation is preliminary and subject to change, including the valuation of intangible assets, income taxes, and goodwill, among other items. The amounts recognized will be finalized as the information necessary to complete the analysis is obtained, but 
no
 later than 
one
 year after the acquisition date. Finalization of the valuation during the measurement period could result in a change in the amounts recorded for the acquisition date fair value.

The following table summarizes the preliminary fair value of assets acquired and liabilities assumed as of the acquisition date:

Preliminary Allocation

(in thousands)

Accounts receivable, net

$
618

Prepaid expenses and other current assets

173

Property and equipment, net

68

Goodwill

17,195

Intangible assets, net

3,943

Operating lease right-of-use assets

562

Other assets

30

Accounts payable

(
347
)

Accrued expenses and other current liabilities

(
374
)

Current portion of deferred revenue

(
2
)

Long-term operating lease liabilities

(
457
)

Other liabilities

(
1,017
)

Total purchase consideration, net of cash acquired

$
20,392

15

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

The goodwill, which is generally 
not
 tax-deductible, is attributed to intangible assets that do 
not
 qualify for separate recognition, including the assembled workforce of the acquired business and the synergies expected to arise as a result of the acquisition.

The following table summarizes the purchase price allocated to the intangible assets acquired:

Amount

Weighted Average Life

(in thousands)

(in years)

Technology and software

$
3,632

6.0

Customer related assets

311

5.0

Fair value of intangible assets acquired

$
3,943

5.9

The estimated fair values of identifiable intangible assets were determined using the multiperiod excess earnings method and distributor method. The multiperiod excess earnings method is a method of estimating the value of the primary income-generating intangible asset within a group of assets, by calculating the cash flow attributable to that asset after deducting contributory asset charges. The distributor method is a form of the multiperiod excess earnings method that relies upon market-based distributor data to value customer relationship intangible assets. Some of the significant assumptions inherent in the development of such asset valuations include revenues, contributory asset charges, discount rate and useful life. The fair value of intangible assets is based on publicly available benchmarking information as well as preliminary assumptions which are subject to change as we complete our valuation procedures.

Mandatorily Redeemable Noncontrolling Interest

As part of the acquisition, the Company agreed to purchase the remaining 
20
% of the outstanding shares of Ydentic. The unconditional purchase obligation is a liability-classified mandatorily redeemable noncontrolling interest with subsequent measurement at its estimated redemption value. The liability was initially recognized at fair value of $
5.5
 million. The Company estimated the fair value of the mandatorily redeemable noncontrolling interest using a Monte Carlo simulation model, with the significant input of risk-free rate at 
4.27
%. The model incorporated multiple random iterations, simulating various potential future price paths over the contractual life of the noncontrolling interest shares, based on appropriate probability distributions.

Subsequent to the initial measurement, mandatorily redeemable noncontrolling interests are measured at the amount of cash that would be paid under the conditions specified in the applicable agreement, assuming settlement occurred as of the reporting date. Any change in the estimated redemption amount compared to the prior reporting date is recognized as interest cost in the condensed consolidated statements of income (loss).

As of 
 September 30, 2025
, the liability was $
6.2
 million and is included in accrued expenses and other current liabilities within the condensed consolidated balance sheets. During the 
three
 and 
nine
 months ended 
 September 30, 2025
, the Company recorded interest income of $
0.9
 million and $
0.1
 million, respectively, to adjust the redemption value of the mandatorily redeemable noncontrolling interest. The interest income is included in other income (expense), net within the condensed consolidated statements of income (loss).

16

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

4.
 Goodwill 

The changes in the carrying amounts of goodwill were as follows:

Goodwill

(in thousands)

Balance, December 31, 2024

$

17,715

Acquisitions

17,195

Effect of foreign currency translation

2,998

Balance, September 30, 2025

$

37,908

5.
 Intangible Assets, Net

Intangible assets consist of acquired intangible assets and self-developed software.

A summary of the balances of the Company’s intangible assets as of 
 September 30, 2025
 and 
 December 31, 2024
 is presented below:

Gross Carrying Amount

Accumulated Amortization

Net Carrying Amount

Gross Carrying Amount

Accumulated Amortization

Net Carrying Amount

September 30, 2025

December 31, 2024

(in thousands)

Technology and software

$
14,408

$
(
5,419
)

$
8,989

$
8,906

$
(
3,446
)

$
5,460

Customer related assets

4,836

(
1,476
)

3,360

4,329

(
1,036
)

3,293

Content

—

—

—

818

(
682
)

136

Total

$
19,244

$
(
6,895
)

$
12,349

$
14,053

$
(
5,164
)

$
8,889

Amortization expense for intangible assets was $
0.8
 million and $
2.4
 for the 
three
 and 
nine
 months ended 
 September 30, 2025
, and $
0.7
 million and $
1.9
 million for the 
three
 and 
nine
 months ended 
 September 30, 2024
, respectively.

As of 
 September 30, 2025
, estimated future amortization expense for intangible assets, net is as follows:

Year Ending December 31:

(in thousands)

2025 (three months)

$
807

2026

3,018

2027

2,500

2028

2,029

2029

1,482

Thereafter

2,513

Total intangible assets subject to amortization

$
12,349

17

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

6.
 Accounts Receivable, Net 

Accounts receivable, net, consists of the following components:

September 30,

December 31,

2025

2024

(in thousands)

Trade receivables

$

66,035

$

68,007

Current unbilled receivables

25,336

20,205

Allowance for credit losses

(
487

)

(
847

)

$

90,884

$

87,365

7.
 Line of Credit 

The Company maintains a loan and security agreement (the “
Loan Agreement
”) with HSBC Bank USA, National Association (“
HSBC
”), as lender, for a revolving line of credit of up to $
30.0
 million, with an accordion feature that provides up to $
20.0
 million of additional borrowing capacity the Company 
 may 
draw upon at its request. Of the 
$30.0
 million line of credit, a sublimit of approximately $
8.1
 million is designated to facilitate the issuance of bank guarantees, including letters of credit. The line bears interest at a rate equal to term 
SOFR
 plus 
3.0
% to 
3.3
% depending on the Consolidated Total Leverage Ratio (as defined in the Loan Agreement). The line carries an unused fee at a rate equal to 
0.5
%. The line will mature on 
 November 3, 2026. 
We are required to maintain a minimum Consolidated Fixed Charge Coverage Ratio (as defined in the Loan Agreement) as well as a maximum Consolidated Total Leverage Ratio, tested by HSBC each quarter. The Company pledged, assigned and granted HSBC a security interest in all shares of its subsidiaries, future proceeds and assets (except for excluded assets, including material intellectual property) as security for the performance of the Loan Agreement obligations. As of 
 September 30, 2025
, the Company is compliant with all covenants under the line and had 
no
 borrowings outstanding under the line of credit.

8.
 Income Taxes

The Company had an effective tax rate of (
1.6
)% and 
20.6
% for the 
three
 and 
nine
 months ended 
 September 30, 2025
, respectively, and 
5.9
% and (
106.5
)% for the 
three
 and 
nine
 months ended 
 September 30, 2024
, respectively.

The change in effective tax rates for the 
three
-month period ended 
 September 30, 2025
 as compared to the 
three
-month period ended 
 September 30, 2024
 was primarily due to the mix of pre-tax income (loss) results by jurisdictions taxed at different rates, the impact of foreign inclusions and stock-based compensation.

The change in effective tax rates for the 
nine
-month period ended 
 September 30, 2025
 as compared to the 
nine
-month period ended 
 September 30, 2024
 was primarily due to the mix of pre-tax income (loss) results by jurisdictions taxed at different rates, the impact of foreign inclusions, stock-based compensation and changes in valuation allowance in certain jurisdictions. 

The Company continues to evaluate the realizability of its deferred tax assets on a quarterly basis and will adjust such amounts in light of changing facts and circumstances. In making such an assessment, management would consider all available supporting data, including the level of historical taxable income, future reversals of existing temporary differences, tax planning strategies, and projected future taxable income.

ASC 
740,

Income Taxes
, requires the effects of changes in tax rates and laws to be recognized in the period in which the legislation is enacted. On 
 July 4, 2025, 
H.R.1
 - One Big Beautiful Bill Act (“
OBBBA
”) was enacted into law. In general, the OBBBA makes permanent key corporate tax elements of the Tax Cuts and Jobs Act and modifies certain international tax provisions. The main provision of the OBBBA that will materially impact our current and deferred income taxes in 
2025
 is the restoration of the ability to immediately expense domestic research and experimental expenditures. The Company will continue to analyze the provisions of the OBBBA for other impacts to its current and deferred income taxes in the 
fourth
 quarter. 

18

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

9.
 Leases

The Company is obligated under various non-cancelable operating leases primarily for office space. The initial terms of the leases expire on various dates through 
2030.
 We determine if an arrangement is a lease at inception.

The components of the Company’s operating lease expenses are reflected in the condensed consolidated statements of income (loss) as follows:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Lease liability cost

$
2,373

$
1,853

$
6,709

$
5,353

Short-term lease expenses 
(1)

378

345

1,214

891

Variable lease cost not included in the lease liability 
(2)

142

163

336

478

Total lease cost

$
2,893

$
2,361

$
8,259

$
6,722

(
1
)
 Short-term lease expenses include rent expenses from leases of 
12
 months or less on the transition date or lease commencement.

(
2
)
 Variable lease cost includes common area maintenance, property taxes, and fluctuations in rent due to a change in an index or rate.

Our lease agreements generally contain lease and non-lease components. Non-lease components primarily include payments for maintenance and utilities. We elected to combine fixed payments for non-lease components, for all classes of underlying assets, with our lease payments and account for them together as a single lease component which increases the amount of our lease assets and liabilities.

During the 
nine
 months ended 
 September 30, 2025
 and 
2024
, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $
9.0
 million and $
5.2
 million, respectively.

Other information related to operating leases is as follows:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Cash paid for amounts included in the measurement of the lease liability:

Operating cash flows from operating leases

$
2,216

$
1,828

$
6,840

$
5,576

As of 
 September 30, 2025
, our operating leases had a weighted average remaining lease term of 
3.2
 years and a weighted average discount rate of 
5.5
%.

19

Table of Contents

            AvePoint, Inc.

            Notes to Condensed Consolidated Financial Statements

            (Unaudited)

       As of

 December 31, 2024, 
our operating leases had a weighted average remaining lease term of

3.3
 years and a weighted average discount rate of

5.2
%.

       The maturity schedule of the operating lease liabilities as of

 September 30, 2025
 is as follows:

Year Ending December 31:

(in thousands)

2025 (three months)

$
2,257

2026

7,962

2027

5,415

2028

2,156

2029

1,671

Thereafter

1,215

Total future lease payments

20,676

Less: Present value adjustment

(
1,773
)

Present value of future lease payments 
(1)

$
18,903

(
1
)
 Includes the current portion of operating lease liabilities of $
7.6
 million, which is reflected in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

As of 
 September 30, 2025
, letters of credit have been issued in the amount of $
1.1
 million as security for operating leases. The letters of credit are secured by a sublimit of our line of credit (refer to “
Note 
7
 - Line of Credit
” for further details). 

20

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

10.
 Commitments and Contingencies

Commitments

The Company has outstanding unconditional purchase commitments to procure licenses to use information technology (“
IT
”) software from suppliers. These agreements are negotiated in consideration of the volume of transactions with select suppliers and the associated required transaction volumes are expected to be met through the normal course of business.

In 
 December 2022, 
the Company signed an unconditional purchase commitment in the amount of $
96.0
 million to purchase IT solutions over a 
three
-year term. Under this agreement, payments are made upon access to the service. Any remaining obligations are due at the end of the 
three
-year term in 
 December 2025 
and to be used through 
 December 2026 
as specified in the agreement. Given the Company’s history of procuring similar products, it is expected that cash payments to the supplier will occur in 
2023
 through 
2025
 with any remaining amounts coming due in 
2025.
 The Company paid $
10.3
 million and $
27.6
 million, respectively, during the 
three
 and 
nine
 months ended 
 September 30, 2025
, and $
7.0
 million and $
20.7
 million, respectively, during the 
three
 and 
nine
 months ended 
 September 30, 2024
, related to the 
 December 2022 
agreement. 

In 
 December 2024, 
the Company signed an unconditional purchase commitment in the amount of $
15.0
 million to purchase additional IT solutions over a 
five
-year term. Under this agreement, payments are made upon access to the service. The agreement specified 
four
 minimum commitment periods. The minimum commitment payments are due at the end of each minimum commitment period.

In 
 February 2024, 
the Company made a commitment to contribute $
50.0
 million to a growth equity fund. As of 
 September 30, 2025
, this commitment remains outstanding. Refer to “
Note

13

-

Growth Equity Fund
” for more information.

Legal Proceedings 

In the normal course of its business, the Company 
 may 
be involved in various claims, negotiations and legal actions. Except for such claims that arise in the normal course of business, as of 
 September 30, 2025
, the Company was 
not
 a party to any other litigation.

Indemnification

The Company has entered into indemnification agreements with its directors and executive officers. These agreements, among other things, require AvePoint to indemnify its directors and executive officers to the fullest extent permitted by Delaware law, specifically the Delaware General Corporation Law (as the same exists or 
 may 
hereafter be amended) for certain expenses, including attorneys’ fees, judgments, fines, and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as 
one
 of the Company’s directors or officers or any other company or enterprise to which the person provides services at the Company’s request.

As part of the business combination with Apex Technology Acquisition Corporation, Inc. (“
Apex
”), we assumed certain indemnification obligations for Apex Technology Sponsor LLC (the “
Sponsor
”) and Jeff Epstein, Brad Koenig, David Chao, Peter Bell, Donna Wells, and Alex Vieux (the “
Indemnitees
” or “
Defendants
”). On 
 February 2, 2024, 
Drulias and Farzad (as purported Apex stockholders, the “
Plaintiffs
”) filed a class action complaint against the Indemnities in Delaware Court of Chancery, captioned Dean William Drulias, et.al. v. Apex Technology Sponsor LLC, et.al., C.A. 
No.

2024
-
0094
-LWW. The Plaintiffs asserted breach of fiduciary duty and unjust enrichment claims against the Defendants. The complaint alleged that the Defendants made false and misleading disclosures in the 
 June 2, 2021 
proxy statement of Apex impacting its stockholders’ vote to approve a merger between Apex and us and also affecting stockholders’ redemption rights prior to the merger. The Plaintiffs sought unspecified damages, rescission or rescissory damages, and disgorgement of unjust enrichment. We were 
not
 a named defendant in the complaint but had indemnification obligations to the Defendants under indemnification agreements executed during the merger. Also, in accordance with the business combination agreement, Apex and the Sponsor obtained insurance policies to cover post-closing liability, with Apex securing a policy with a limit of $
10
 million and the Sponsor securing a policy with a limit of $
3
 million. The parties participated in a mediation in 
 October 2024 
and agreed to settlement terms. Pursuant to a fully executed settlement agreement, releasing us and the Defendants and settling the class action, we contributed $
1.4
 million in the 
second
 quarter toward the total settlement amount of $
14.4
 million. The remaining $
13
 million was paid pursuant to the 
two
 aforementioned insurance policies covering the Defendants and the Sponsor. As of 
 September 30, 2025
 and 
 December 31, 2024, 
an estimated accrual of $
0.0
 million and $
1.4
 million, respectively, was included in the accrued expenses and other current liabilities within the condensed consolidated balance sheets.

Guarantees
﻿

In the normal course of business, customers in certain geographies or in highly regulated sectors occasionally require contingency agreements for the completion of service projects, the completion of which are secured by a sublimit of our line of credit (refer to “
Note 
7
 - Line of Credit
” for further details). As of 
 September 30, 2025
, letters of credit for customer-related contingency agreements have been issued in the amount of $
5.8
 million, as security for the agreements. These agreements have 
not
 had a material effect on our results of operations, financial position or cash flow.

21

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

11.
 Warrant Liabilities

Private Warrants to Acquire Common Stock

On 
 July 1, 2021, 
the Company granted 
405,000
 private placement warrants with a 
5
-year term and an exercise price of $
11.50
 per share. Management has determined that the private placement warrants are to be classified as liabilities to be marked to market at each reporting period.

The private placement warrants are non-transferable and any transfer to an unrelated party would cause the warrants to be converted into public warrants. Consequently, the fair value of the private placement warrants is equivalent to the quoted price of the publicly traded warrants. Under this approach, the fair value of the private placement warrants on 
 July 1, 2021, 
was determined to be $
1.4
 million. On 
 April 10, 2025 (
the “
Private Warrants Transfer Date
”), the private placement warrants were transferred to an unrelated party and converted into public warrants. As a result, the public warrants were reclassified from other liabilities to additional paid-in capital in the consolidated balance sheets by $
1.5
 million. Following the reclassification, there were 
no
 remaining private placement warrants. The fair value was remeasured as of the Private Warrants Transfer Date and 
 December 31, 2024
, and was determined to be $
1.5
 million and $
1.9
 million, respectively, and included in other liabilities in the condensed consolidated balance sheets. During the 
three
 and 
nine
 months ended 
 September 30, 2025
, a $
0.0
 million and a $
0.4
 million decrease in liability was recognized respectively, and during the 
three
 and 
nine
 months ended 
 September 30, 2024
, a $
0.3
 million and $
0.5
 million increase in liability was recognized, respectively, and included as other income (expense), net in the condensed consolidated statements of income (loss).

12.
 Stockholders
’
 Equity

The Company has 
one
 class of capital stock: common stock. The following summarizes the terms of the Company’s capital stock.

Common Stock 

Pursuant to the Company’s restated Articles of Incorporation, the Company was authorized to issue up to 
1,000,000,000
 shares of common stock at $
0.0001
 par value. There were 
212,587,772
 and 
194,070,512
 shares issued and outstanding as of 
 September 30, 2025
 and 
 December 31, 2024
, respectively. Each share of common stock is entitled to 
one
 vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Company’s Board of Directors. The Company’s Board of Directors has 
not
 declared common stock dividends since inception.

Share Repurchase Program

On 
 March 17, 2022, 
the Company announced that its Board of Directors authorized a new share repurchase program (the “
Share Repurchase Program
”) for the Company to buy back shares of its common stock for a period of 
three
 years from the date of authorization. On 
 February 25, 2025, 
the Company’s Board of Directors renewed the Share Repurchase Program for an additional 
three
 years from the date of renewal. Under the Share Repurchase Program, the Company has the authority to buy up to $
150
 million of common stock via acquisitions in the open market or privately negotiated transactions. The Share Repurchase Program 
 may 
be suspended or discontinued at any time. The Company is 
not
 obligated to make purchases of, nor is it obligated to acquire any particular amount of, common stock under the Share Repurchase Program. During the 
nine
 months ended 
 September 30, 2025
﻿, the Company repurchased and retired 
1,743,455
 shares at an average price of $
15.66
 per share. The shares were returned to the status of authorized but unissued shares. As a result, common stock amount, additional paid-in capital, and accumulated deficit in the condensed consolidated balance sheet during the 
nine
 months ended 
 September 30, 2025
, were reduced by $
0.0
 million, $
7.7
 million, and $
19.6
 million, respectively. During the 
nine
 months ended 
 September 30, 2024
, the Company repurchased and retired 
2,629,978
 shares at an average price of $
8.25
 per share.

22

Table of Contents

           AvePoint, Inc.

           Notes to Condensed Consolidated Financial Statements

           (Unaudited)

Public Warrants to Acquire Common Stock

On 
 July 1, 2021, 
the Company issued 
17,500,000
 public warrants with an exercise price of $
11.50
. Each warrant entitles the registered holder to purchase 
one
 share of AvePoint’s common stock and the warrants are exercisable from the date of issuance through 
 July 1, 2026.

The Company 
 may 
call the public warrants for redemption as follows: (
1
) in whole and 
not
 in part; (
2
) at a price of $
0.01
 per warrant; (
3
) upon a minimum of 
30
 days prior written notice of redemption; and (
4
) only if the last reported closing price of the common stock equals or exceeds $
18.00
 per share for any 
20
 trading days within a 
30
 trading day period ending on the 
3rd
 trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

On 
 June 6, 2025, 
the last sales price of the Company’s Common Stock was at least $
18.00
 per share on each of 
20
 trading days within a 
30
-trading day period. On 
 July 
16,

2025,
 the Company redeemed all 
189,496
 public warrants that remained outstanding as of 
 July 11, 2025 (
the “
Redemption Date
”), at a redemption price of $
0.01
 per warrant.

During the 
nine
 months ended 
 September 30, 2025
﻿, 
14,625,054
 warrants were exercised, with total cash proceeds of $
168.2
 million. As of 
 September 30, 2025
, 
no
 warrants remained outstanding.

Noncontrolling Interest

On 
 May 30, 2025
,
 the Company repurchased all of the remaining outstanding interest of MaivenPoint Ptd. Ltd. (“
MaivenPoint
”) from the remaining minority interest holders for an aggregate cash purchase price of $
12.1
 million. Following the repurchase of the interest, the Company is the sole interest holder of MaivenPoint. As of 
 December 31, 2024, 
AvePoint owned 
76.1
% interest in MaivenPoint.

13.
 Growth Equity Fund

On 
 February 28, 2024, 
the Company and Lumens Capital Partners Ltd. (“
LCP
”) established 
A3V
 JV Co. (the “
Venture
”), with each owning an equal share of the Venture. In addition, the Company entered into a separate agreement with LCP to form 
A3
 Ventures Fund 
1,
 L.P. (the “
Fund
”). The Fund is a Cayman Islands-exempted limited partnership, aimed at investing in companies in the growth equity phase and mature cashflow generating businesses with strong growth potential. The Fund looks to invest in companies situated in enterprise software markets aligning with the professional expertise and geographical presence of both the Company and LCP.

The Venture wholly owns 
A3V
 GP Co., which serves as the general partner of the Fund. As a limited partner, the Company committed to contribute $
50.0
 million to the Fund, to be called as needed, for portfolio investments, fees, and expenses of the Fund. The Company also participates in Fund establishment costs and an annual management fee equal to 
2.0
% of the total commitment. Any future repayment obligations will be triggered upon the receipt by LCP of profit allocations related to the Fund.

As of 
 September 30, 2025
, 
no
 portion of the Company’s $
50.0
 million commitment has been called or was callable.

The Company also recorded management fees and establishment costs of $
0.3
 million and $
0.8
 million for the 
three
 and 
nine
 months ended 
 September 30, 2025
﻿, respectively, and $
0.6
 million and $
1.9
 million for the  
three
 and 
nine
 months ended 
 September 30, 2024
, respectively, were included in general and administrative in the condensed consolidated statements of income (loss).

In 
 September 
2025,
 the Company decided to discontinue its participation in the Fund. As a result, during the 
three
 and 
nine
 months ended 
 September 30, 2025, 
the Company recorded a credit loss of $
3.5
 million, offset by a reduction of $
1.6
 million of accrued expenses. Both were included in general and administrative in the condensed consolidated statement of income (loss). During the 
three
 and 
nine
 months ended 
 September 30, 2025 
the Company also recorded a $
0.5
 million interest loss included in other income (expense), net in the condensed consolidated statement of income (loss).

As of 
 September 30, 2025 
and 
 December 31, 2024, 
an estimated payable of $
1.6
 million and $
2.4
 million, respectively, was included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

23

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

14.
 Stock-Based Compensation 

The Company maintains the 
2021
 Equity Incentive Plan (the “
2021
 Plan
”). As of 
 September 30, 2025
, 
36,591,511
 shares remained for future issuance under the 
2021
 Plan. To date, the Company has issued only stock options and restricted stock units to employees, directors and consultants.

Total stock-based compensation expense was $
10.7
 million and $
31.4
 million for the 
three
 and 
nine
 months ended 
 September 30, 2025
﻿, respectively, and was $
9.8
 million and $
29.8
 million for 
three
 and 
nine
 months ended 
 September 30, 2024
, respectively.

Stock Options 

The compensation costs for stock option awards are recognized using the straight-line attribution method over the requisite service period and are accounted for forfeitures as they occur. Stock options vest over a 
four
-year service period and expire on the 
tenth
 anniversary of the date of award. 

On 
 March 14, 2025, 
the Company granted 
269,685
 options under the 
2021
 Plan, at a total grant-date fair value of $
2.2
 million. The Company estimated the grant date fair value of these stock options using the Black-Scholes option-pricing model with the following weighted-average assumptions:

March 14,

2025

Expected life (in years)

6.1

Expected volatility

55.6
%

Risk-free rate

4.1
%

Dividend yield

—

As of 
 September 30, 2025
, there was $
4.2
 million in unrecognized compensation costs related to all unvested options.

As of 
 September 30, 2025
, the Company had 
21,778,971
 options outstanding and 
20,794,282
 options exercisable with intrinsic values of $
231.5
 million and $
224.8
 million, respectively. During the 
nine
 months ended 
 September 30, 2025
, 
1,679,075
 options were exercised, with a total intrinsic value of $
21.1
 million.

24

Table of Contents

         AvePoint, Inc.

         Notes to Condensed Consolidated Financial Statements

         (Unaudited)

Restricted Stock Units

Under the terms of the 
2021
 Plan, we have issued restricted stock unit awards with a continuous employment condition only (“
Time-Based RSUs
”), and restricted stock unit awards with a continuous employment condition that are also contingent on the Company meeting certain performance goals (“
PSUs
”, and together with Time-Based RSUs, “
RSUs
”). Both types of RSU awards vest over a 
four
-year period from the grant date.

2,120,211
 Time-Based RSUs and 
301,842
 PSUs were granted under the 
2021
 Plan during the 
nine
 months ended 
 September 30, 2025
, with a weighted-average grant date fair-value of $
14.76
 per award. The compensation costs for RSUs are recognized using the straight-line attribution method over the requisite service period and are accounted for forfeitures as they occur. RSUs are measured at the fair market value of the underlying stock at the grant date. RSUs that vested during the 
nine
 months ended 
 September 30, 2025
 had an aggregate fair value at vesting of $
64.4
 million. As of 
 September 30, 2025
, there was $
61.9
 million in unrecognized compensation costs specific to the unvested RSUs, to be recognized over a weighted-average period of 
2.6
 years. As of 
 September 30, 2025
, the Company had 
7,007,132
 unvested Time-Based RSUs and 
804,518
 unvested PSUs with a weighted-average grant date fair-value of $
8.79
 per award.

15.
 Fair Value Measurements

Fair value is the price that would be received upon selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value are measured and classified in accordance with a 
three
-level fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The 
three
 levels of inputs used to measure fair value are as follows:

•

Level 
1
 — Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

•

Level 
2
 — Inputs other than quoted prices included within Level 
1
 that are observable for the asset or liability, either directly or indirectly.

•

Level 
3
 — Unobservable inputs for the asset or liability.

25

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

Financial assets and liabilities measured at fair value on a recurring basis are classified in the categories described in the table below:

September 30, 2025

(in thousands)

Level 1

Level 2

Level 3

Total

Assets

Cash Equivalents:

Certificates of deposit 
(1)

$
—

$
1,704

$
—

$
1,704

Money market funds

—

4,204

—

4,204

U.S. treasury bills

—

187,127

—

187,127

Prepaid expenses and other current assets:

Certificates of deposit 
(1)

—

339

—

339

Other assets:

Certificates of deposit 
(1)

—

206

—

206

Total

$
—

$
193,580

$
—

$
193,580

Liabilities:

Accrued expenses and other current liabilities:

Mandatorily redeemable noncontrolling interest 
(2)

$
—

$
—

$
5,679

$
5,679

Total

$
—

$
—

$
5,679

$
5,679

December 31, 2024

(in thousands)

Level 1

Level 2

Level 3

Total

Assets

Cash Equivalents:

Certificates of deposit 
(1)

$
—

$
1,504

$
—

$
1,504

Money market funds

—

4,188

—

4,188

U.S. treasury bills

—

181,210

—

181,210

Prepaid expenses and other current assets:

Certificates of deposit 
(1)

—

165

—

165

Other assets:

Certificates of deposit 
(1)

—

39

—

39

Notes receivables
 (3)

—

—

3,938

3,938

Total

$
—

$
187,106

$
3,938

$
191,044

Liabilities:

Other liabilities:

Warrant liabilities 
(4)

$
—

$
1,861

$
—

$
1,861

Total

$
—

$
1,861

$
—

$
1,861

(
1
) 
The majority of certificates of deposit are foreign deposits.

(
2
) 
The fair value of mandatorily redeemable noncontrolling interest is based on discounted redemption value using risk-free rates offered for similar financing with the same remaining maturities.

(
3
)
 During 
2023,
 the Company extended a credit facility to LCP with a total commitment of up to $
5.0
 million and maturities of greater than 
twelve
 months (the “
LCP Notes Receivable
”). Refer to “
Note 
13

—
 Growth Equity Fund
” for further details. The LCP Notes Receivable bear interest at an annual rate equal to 
8
%. As of 
 December 31, 2024
, the LCP Notes Receivable in the amounts of $
3.8
 million was included in other assets within the condensed consolidated balance sheets. Fair value is based on discounted future cash flows using current interest rates offered for similar notes to 
third
 parties with similar credit ratings for the same remaining maturities. 

(
4
) 
Refer to “
Note 
11
 — Warrant Liabilities
” for further details.

26

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

The following tables summarize the Company’s available-for-sale securities measured at fair value as of 
 September 30, 2025
 and 
 December 31, 2024
.

September 30, 2025

(in thousands)

Amortized Cost

Fair Value

Gross Unrealized Gains

U.S. treasury bills

$
187,106

$
187,127

$
21

Total

$
187,106

$
187,127

$
21

December 31, 2024

(in thousands)

Amortized Cost

Fair Value

Gross Unrealized Losses

U.S. treasury bills

$
181,217

$
181,210

$
(
7
)

Total

$
181,217

$
181,210

$
(
7
)

The contractual maturity of the available-for-sale securities held as of 
 September 30, 2025
 and 
 December 31, 2024
 was within 
one
 year.

16.
 Segment Information

The Company manages its business activities on a consolidated basis and operates in a 
single
 operating segment. Its products and services are sold throughout the world, through direct and indirect sales channels. The Company’s chief operating decision maker (the “
CODM
”) is the Chief Executive Officer. The CODM makes operating performance assessment and resource allocation decisions on a consolidated basis. The CODM does 
not
 review assets in evaluating the results of the segment.

The CODM assesses performance for the consolidated entity and decides how to allocate resources based on net income (loss) reported on the consolidated statements of income (loss). The CODM uses net income (loss) to monitor budgeted versus actual results and to conduct competitive analysis by benchmarking against industry peers. Additionally, net income (loss) serves as a basis for making strategic decisions, such as acquisitions and reinvestments into the business, and establishing management compensation linked to segment performance.

The following table sets forth the information about the Company’s reported segment revenue, segment profit or loss, and significant segment expenses:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Revenue:

$
109,728

$
88,804

$
304,810

$
241,299

Less:

People expenses

56,267

46,698

164,010

138,017

Stock-based compensation

10,678

9,811

31,441

29,807

Cloud and server hosting services expenses

11,825

8,332

32,019

23,493

Marketing expenses

2,943

2,844

10,756

8,819

Other segment items 
(1)

14,998

18,191

47,108

53,127

Net income (loss)

$
13,017

$
2,928

$
19,476

$
(
11,964
)

(
1
)
 The other segment items category includes professional services, rent, software maintenance, travel, depreciation and amortization, certain overhead expense, and mark-to-market of earn-out shares liabilities and warrant liabilities.

27

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

Revenue by geography is based upon the billing address of the customer. All transfers between geographic regions have been eliminated from consolidated revenue. The following table sets forth revenue by geographic area:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Revenue:

North America

$
43,094

$
37,648

$
119,117

$
99,240

EMEA

35,454

26,298

96,760

72,193

APAC

31,180

24,858

88,933

69,866

Total revenue

$
109,728

$
88,804

$
304,810

$
241,299

The following table sets forth revenue generated by countries which represent more than 
10%
 of total consolidated revenue:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Revenue:

United States

$
42,485

$
37,518

$
118,051

$
98,744

Germany

15,185

11,568

40,680

30,856

Singapore

12,900

10,700

38,205

31,409

28

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

17.
 Other Income (Expense), Net

Other income (expense), net is disaggregated as follows:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Change in value of earn-out and warrant liabilities

$

—

$

(
4,537

)

$

408

$

(
11,717

)

Interest income, net

2,385

45

3,457

116

Gain on securities 
(1)

2,000

2,383

5,906

7,136

Foreign currency exchange (loss) gain, net

(
254

)

237

(
4,000

)

(
975

)

Other, net

547

(
2,669

)

253

(
2,667

)

Other income (expense), net

$

4,678

$

(
4,541

)

$

6,024

$

(
8,107

)

(
1
)
 Gain on securities consist of interest income from amortization of the discount arising at acquisition of U.S. treasury bills.

18.
 Net Income (Loss) Per Share 

Basic net income (loss) per share is computed by dividing total net income (loss) by the weighted average common shares outstanding for the period. In computing diluted net income (loss) per share, the Company adjusts the denominator, subject to anti-dilution requirements, to include the dilution from potential shares of common stock resulting from outstanding share-based payment awards, warrants and Company earn-outs. 

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands, except per share amounts)

Net income (loss) per share available to common stockholders, excluding sponsor earn-out stockholders

Numerator:

Net income (loss)

$

13,017

$

2,928

$

19,476

$

(
11,964

)

Net income attributable to Sponsor Earn-out Shares

—

(
41

)

—

—

Net (income) loss attributable to noncontrolling interest

—

(
308

)

(
321

)

59

Total net income (loss) available to common stockholders

$

13,017

$

2,579

$

19,155

$

(
11,905

)

Denominator:

Weighted average common shares outstanding

212,001

183,946

205,049

182,753

Effect of dilutive securities

Stock options

15,985

14,533

16,430

—

RSUs

4,874

5,380

5,659

—

Warrants

37

—

1,847

—

Weighted average diluted shares

232,897

203,859

228,985

182,753

Basic net income (loss) per share available to common stockholders, excluding sponsor earn-out stockholders

$

0.06

$

0.01

$

0.09

$

(
0.07

)

Diluted net income (loss) per share available to common stockholders, excluding sponsor earn-out stockholders

$

0.06

$

0.01

$

0.08

$

(
0.07

)

29

Table of Contents

        AvePoint, Inc.

        Notes to Condensed Consolidated Financial Statements

        (Unaudited)

The below table includes the total potentially dilutive securities for the 
three
 and 
nine
 months ended 
 September 30, 2025
 and 
2024
, which have been excluded from the computation of diluted net income (loss) per share as their effect is anti-dilutive:

Three Months Ended September 30,

Nine Months Ended September 30,

2025

2024

2025

2024

(in thousands)

Stock options

86

12

64

25,195

RSUs

3

1

3

10,534

Warrants

—

16,308

—

16,308

Earn-out shares

—

3,000

—

3,000

Total

89

19,321

67

55,037

19.
 Subsequent Events

No
 material subsequent events occurred since the date of the most recent balance sheet period reported.

       30

Table of Contents

       Part I

       Item 2

ITEM 2. MANAGEMENT
’
S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (Part I, Item 2 of this Quarterly Report) (“
MD&A
”) summarizes (and is intended to help the reader understand) the significant factors affecting the consolidated operating results, financial condition, liquidity and cash flows of our Company as of and for the periods presented below. The MD&A should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2024 (our “
Annual Report
”) and our condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report. 

Third Quarter 2025 Business Highlights

         ▪

Total annual recurring revenue (“
ARR
”) increased 26% year-over-year to $390.0 million as of September 30, 2025;

         ▪

Total revenue increased 24% year-over-year to $109.7 million for the three months ended September 30, 2025, 21% on a constant currency basis;

        ▪

SaaS revenue increased 38% year-over-year to $84.0 million for the three months ended September 30, 2025, 35% on a constant currency basis;

        ▪

Announced its listing on the Main Board of Singapore Exchange Securities Trading Limited (the “
SGX-ST
”) under the symbol “AVP”, making AvePoint the first B2B SaaS stock to be listed on the SGX-ST and the first company to be dual listed on both Nasdaq and the SGX-ST. 

Overview 

AvePoint empowers organizations of all sizes, industries, and regions with its cloud-native data management software platform, enabling them to prepare, secure, and optimize their critical data. The AvePoint Confidence Platform unifies data security, governance, and business continuity into a seamless, resilient experience, addressing the most pressing challenges in today’s complex digital landscape.

In a world where data is sprawling across hybrid work environments and generative artificial intelligence (“
AI
”) technologies are rapidly emerging, AvePoint stands out with its platform-first strategy. By integrating features and solutions to optimize operations, AvePoint delivers more than basic security controls—it redefines how businesses manage their most sensitive data and critical assets. This holistic and automated approach enables organizations to secure the perimeter for sensitive data, strategically govern digital workspaces, and ensure compliance with evolving regulatory requirements.

Organizations today face a host of challenges that make a robust data management strategy indispensable, including:

■

Optimizing

data for AI:
 As organizations modernize their data ecosystems, the complexities of leveraging generative AI technologies require proper governance, security, and lifecycle management. With AvePoint, companies can extract more value from complex datasets, make informed decisions, reduce workloads, and enhance customer experiences.

■

Explosive data growth:
 The hybrid work model and SaaS proliferation have led to a surge in unstructured, sensitive data. AvePoint’s solutions tackle the sprawl with robust control and protection measures to manage this growth.

■

A dangerous threat landscape and complex regulations:
 Companies are navigating increasing cyber threats and global regulatory demands. AvePoint ensures data is protected, secure, and compliant, helping mitigate financial, operational, and reputational risks.

■

The need for automation:
 To monitor, govern, and respond to threats efficiently, organizations require streamlined, automated platforms that deliver rapid value. AvePoint’s automation layer integrates seamlessly to achieve this efficiency.

Guided by its 
Beyond Secure 
philosophy, AvePoint goes beyond traditional boundaries to inspire trust, enabling organizations to focus on innovation while protecting against data breaches and unauthorized access. For over 20 years, AvePoint has continually innovated to provide solutions that meet the demands of modern data management, empowering businesses to overcome challenges and unlock new possibilities in an ever-evolving landscape.

     31

Table of Contents

       Part I

       Item 2

Key Business Metric

Our management reviews the following key business metric to measure our performance, identify trends affecting our business, formulate business plans, make strategic decisions, and effectively allocate resources. We believe that both management and investors benefit from referring to this metric to evaluate progress against our growth strategies and gain additional transparency into performance trends.

September 30,

2025

2024

Total ARR ($ in mil)

$

390.0

$

308.9

Annual Recurring Revenue

We believe ARR further enables measurement of our business performance, is an important metric for financial forecasting, and better enables us to make strategic business decisions. We calculate ARR as the annualized sum of contractually obligated Annual Contract Value (“
ACV
”) from SaaS, term license and support, and maintenance revenue sources from all active customers at the end of a reporting period.

As of September 30, 2025 and September 30, 2024, total ARR was $390.0 million and $308.9 million, respectively, representing growth of 26% year over year, both on a reported basis and when adjusted for FX. 

Growth in ARR is driven by both new customer acquisitions and the expansion of existing customer relationships. ARR should be viewed independently of revenue and deferred revenue and is not intended to be combined with or replace these items. ARR is not a forecast of future revenue, and the active contracts used in calculating ARR may or may not be extended or renewed by our customers.

       32

Table of Contents

       Part I

       Item 2

Components of Results of Operations 

Revenue

We generate revenue from four primary sources: SaaS, term license and support, services, and maintenance. We consider SaaS, term license and support, and maintenance revenues to be recurring.

SaaS revenues are generated from our cloud-based solutions. Term license and support revenues are generated from the sales of on-premise or hybrid licenses, which include a distinct support component. Both SaaS and term license and support revenues are primarily billed annually. SaaS and term license and support are generally sold per user license or based upon the amount of data protected. SaaS revenue is recognized ratably over the term of the contract. For term license and support revenue, the license component is generally recognized upfront at the point in time when the software is made available to the customer to download and use, and the support component is recognized ratably over the term of the contract.

Services revenue includes revenue generated from implementation, training, consulting, license customization and managed services. These revenues are recognized by applying a measure of progress, such as labor hours, to determine the percentage of completion of each contract. These offerings are not inherently recurring in nature and as such are subject to more period-to-period volatility than other elements of our business. Services revenue from managed services are recognized ratably or on a straight-line basis over the contract term.

Maintenance revenue is a result of selling on-going support for legacy perpetual licenses. It also includes recurring professional services such as technical account management. Maintenance revenue is recognized ratably over the term of the maintenance agreement, which is typically one year.

Cost of Revenue

Cost of SaaS and cost of term license and support consists of all direct costs to deliver and support our SaaS and term license and support products, including salaries, benefits, stock-based compensation and related expenses, overhead, third-party hosting fees related to our cloud services, and depreciation and amortization. We recognize these expenses as they are incurred. We expect that these costs will increase in absolute dollars but may fluctuate as a percentage of SaaS and term license and support revenue from period to period.

Cost of maintenance consists of all direct costs to support our legacy perpetual license products, including salaries, benefits, stock-based compensation and related expenses, overhead, and depreciation and amortization. We recognize these expenses as they are incurred. We expect that cost of maintenance revenue will decrease in absolute dollars as maintenance revenue declines but may fluctuate as a percentage of maintenance revenue.

Cost of services consists of salaries, benefits, stock-based compensation and related expenses for our services organization, overhead, technology necessary to service our customers, and depreciation and amortization. We recognize these expenses as they are incurred.

Gross Profit and Gross Margin

Gross profit is revenue less cost of revenue, and gross margin is gross profit as a percentage of revenue.

Gross profit has been and will continue to be affected by various factors, including the mix of our revenue, the costs associated with third-party cloud-based hosting services for our cloud-based subscriptions, and the extent to which we expand our customer support and services organizations. We expect that our gross margin will fluctuate from period to period depending on the interplay of these various factors but should increase in the long term as SaaS revenue continues to increase as a percentage of total revenue.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel-related expenses for sales, marketing and customer success personnel, stock-based compensation expense, sales commissions, marketing programs, travel-related expenses, overhead costs, depreciation and amortization. We focus our sales and marketing efforts on creating sales leads and establishing and promoting our brand. Incremental sales commissions for new customer contracts are deferred and amortized ratably over the estimated period of our relationship with such customers. We plan to continue our investment in sales and marketing by hiring additional sales and marketing personnel, executing our go-to-market strategy globally, and building our brand awareness.

       33

Table of Contents

       Part I

       Item 2

General and Administrative

General and administrative expenses consist primarily of personnel-related expenses for finance, legal and compliance, human resources, and IT personnel, as well as stock-based compensation expense, external professional services, overhead costs, other administrative functions, depreciation and amortization. 

Research and Development

Research and development expenses consist primarily of personnel-related expenses incurred for our engineering and product and design teams, as well as stock-based compensation expense, overhead costs, depreciation and amortization. We have a geographically dispersed research and development presence in the United States, China, Singapore and Vietnam. We believe this provides a strategic advantage, allowing us to invest efficiently in both new product development and increasing our existing product capabilities. We believe delivering expanding product functionality is critical to enhancing the success of existing customers while new product development further reinforces our breadth of software solutions.

Other Income (Expense), net

Other Income (Expense), net consists primarily of realized gains/losses for securities, foreign currency remeasurement gains/losses, and fair value adjustments on earn-out and warrant liabilities. 

Income Taxes

We are subject to income taxes in the U.S. (federal and state) and numerous foreign jurisdictions. Tax laws, regulations, administrative practices, principles, and interpretations in various jurisdictions may be subject to significant change, with or without notice, due to economic, political, and other conditions. The foreign jurisdictions in which we operate have different statutory tax rates than those of the United States. Accordingly, our effective tax rate could be affected by the relative proportion of foreign to domestic income, use of foreign tax credits, changes in the valuation of our deferred tax assets and liabilities, applicability of any valuation allowances, and changes in tax laws in jurisdictions in which we operate.

On July 4, 2025, the OBBBA was signed into law. The OBBBA includes various provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The OBBBA has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are currently assessing its impact on our consolidated financial statements and will recognize the income tax effects in the consolidated financial statements beginning in the period in which the OBBBA was signed into law.

     34

Table of Contents

       Part I

       Item 2

Results of Operations 

The below period-to-period comparisons of operating results are not necessarily indicative of results for future periods.

Comparison of Three Months Ended September 30, 2025 and September 30, 2024

Revenue

The components of AvePoint’s revenue during the three months ended September 30, 2025 and 2024 were as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Revenue:

SaaS

$

83,982

$

60,866

$

23,116

38.0

%

Term license and support

11,143

14,140

(2,997

)

(21.2

)%

Services

13,766

10,810

2,956

27.3

%

Maintenance

837

2,988

(2,151

)

(72.0

)%

Total revenue

$

109,728

$

88,804

$

20,924

23.6

%

Total revenue increased 23.6% to $109.7 million for the three months ended September 30, 2025, primarily due to an increase in SaaS revenue, which increased 38.0% to $84.0 million, and represented 77% of total revenue, up from 69% of total revenue in the prior year. The increase in SaaS revenue, which was driven by strong customer demand for our SaaS solutions, was partially offset by an expected decrease in term license and support and maintenance revenues. The growth in total revenue was also due to an increase in services revenue, which grew 27.3% to $13.8 million.

Services revenue is expected to fluctuate as the services generally are not recurring in nature. Additionally, maintenance revenue is expected to continue declining as we have shifted away from the sale of perpetual licenses and towards SaaS and term licenses. Without perpetual license sales, there will be limited opportunities to sell maintenance contracts to new customers. Existing customers have and will continue to transition to SaaS and term licenses, which will continue the decline in maintenance revenue. 

Revenue by geographic region for the three months ended September 30, 2025 and 2024 was as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

North America

$

43,094

$

37,648

$

5,446

14.5

%

EMEA

35,454

26,298

9,156

34.8

%

APAC

31,180

24,858

6,322

25.4

%

Total

$

109,728

$

88,804

$

20,924

23.6

%

For the three months ended September 30, 2025, North America revenue increased 14.5% to $43.1 million, driven by a 36.5%, or $9.6 million, increase in SaaS revenue, partially offset by a combined $4.2 million decrease in term license and support, services, and maintenance revenues. EMEA revenues increased 34.8% to $35.5 million, driven by a 42.2%, or $9.4 million, increase in SaaS revenue, partially offset by a combined $0.2 million net decrease in term license and support, services, and maintenance revenues. APAC revenues increased 25.4% to $31.2 million, primarily driven by a 33.5%, or $4.1 million, increase in SaaS revenue, a 34.2%, or $3.0 million, increase in services revenue, a 44.8%, or $1.0 million, increase in term license and support revenue, partially offset by a $1.8 million decrease in maintenance revenues. 

On a constant currency basis, EMEA revenues increased 27.5%, while EMEA SaaS revenues increased 34.5%. On a constant currency basis, APAC revenues increased 24.5%, while APAC SaaS revenues increased 33.4%.

       35

Table of Contents

       Part I

       Item 2

Non-GAAP Financial Measures

In addition to our financial results determined in accordance with GAAP, we disclose non-GAAP cost of revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP sales and marketing expense, non-GAAP general and administrative expense, non-GAAP research and development expense, non-GAAP operating income and non-GAAP operating margin.

We believe these non-GAAP measures aid investors by providing additional insight into our operational performance and into trends affecting our business. Management uses these non-GAAP financial measures to understand and compare operating results across accounting periods, for internal budgeting and forecasting purposes, and to evaluate financial performance.

Non-GAAP operating income and non-GAAP operating margin should not be considered as an alternative to operating income, operating margin or any other performance measures derived in accordance with GAAP as measures of performance. Non-GAAP operating income and non-GAAP operating margin should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP.

Cost of Revenue, Gross Profit, and Gross Margin

Cost of revenue, gross profit, and gross margin during the three months ended September 30, 2025 and 2024 were as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Cost of revenue:

SaaS

$

14,596

$

10,624

$

3,972

37.4

%

Term license and support

278

373

(95

)

(25.5

)%

Services

13,255

10,057

3,198

31.8

%

Maintenance

16

167

(151

)

(90.4

)%

Total cost of revenue

$

28,145

$

21,221

$

6,924

32.6

%

Gross profit

81,583

67,583

14,000

20.7

%

Gross margin

74.4

%

76.1

%

—

—

GAAP cost of revenue

$

28,145

$

21,221

$

6,924

32.6

%

Stock-based compensation expense

(409

)

(530

)

121

(22.8

)%

Amortization of acquired intangible assets

(360

)

(242

)

(118

)

48.8

%

Non-GAAP cost of revenue

$

27,376

$

20,449

$

6,927

33.9

%

Non-GAAP gross profit

82,352

68,355

13,997

20.5

%

Non-GAAP gross margin

75.1

%

77.0

%

—

—

Cost of revenue increased 32.6% to $28.1 million for the three months ended September 30, 2025, primarily driven by a $3.5 million increase from higher aggregate hosting costs resulting from increased SaaS revenue and a $2.7 million increase in personnel costs. 

       36

Table of Contents

       Part I

       Item 2

Operating Expenses 

Sales and Marketing

Sales and marketing expenses during the three months ended September 30, 2025 and 2024 were as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Sales and marketing

$

35,593

$

30,050

$

5,543

18.4

%

Percentage of revenue

32.4

%

33.8

%

—

—

GAAP sales and marketing

$

35,593

$

30,050

$

5,543

18.4

%

Stock-based compensation expense

(2,679

)

(2,186

)

(493

)

22.6

%

Amortization of acquired intangible assets

(117

)

(120

)

3

(2.5

)%

Non-GAAP sales and marketing

$

32,797

$

27,744

$

5,053

18.2

%

Non-GAAP percentage of revenue

29.9

%

31.2

%

—

—

Sales and marketing expenses increased 18.4% to $35.6 million for the three months ended September 30, 2025, primarily driven by a $5.2 million increase in personnel costs.

General and Administrative 

General and administrative expenses during the three months ended September 30, 2025 and 2024 were as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

General and administrative

$

23,925

$

17,043

$

6,882

40.4

%

Percentage of revenue

21.8

%

19.2

%

—

—

GAAP general and administrative

$

23,925

$

17,043

$

6,882

40.4

%

Stock-based compensation expense

(5,515

)

(4,925

)

(590

)

12.0

%

Secondary listing costs

(2,941

)

—

(2,941

)

100.0

%

Discontinuation of growth equity fund

(1,917

)

—

(1,917

)

100.0

%

Non-GAAP general and administrative

$

13,552

$

12,118

$

1,434

11.8

%

Non-GAAP percentage of revenue

12.4

%

13.6

%

—

—

General and administrative expenses increased 40.4% to $23.9 million for the three months ended September 30, 2025. The increase was primarily driven by $2.9 million of one-time costs related to the Company’s secondary listing on the SGX-ST, a $2.1 million increase in personnel costs, and $1.9 million of costs related to the discontinuation of the Company’s participation in A3 Ventures Fund 1, L.P. (the "
Fund
").

       37

Table of Contents

       Part I

       Item 2

Research and Development 

Research and development expenses during the three months ended September 30, 2025 and 2024 were as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Research and development

$

13,936

$

12,838

$

1,098

8.6

%

Percentage of revenue

12.7

%

14.5

%

—

—

GAAP research and development

$

13,936

$

12,838

$

1,098

8.6

%

Stock-based compensation expense

(2,075

)

(2,170

)

95

(4.4

)%

Non-GAAP research and development

$

11,861

$

10,668

$

1,193

11.2

%

Non-GAAP percentage of revenue

10.8

%

12.0

%

—

—

Research and development expenses 

   increased

   8.6%

 to 

   $13.9

 million for the three months ended 

   September 30, 2025

, primarily driven by a $0.7 million increase in personnel costs. 

Income Tax Provision

Income tax expense during the three months ended September 30, 2025 and 2024 was as follows:

Three Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Income tax (benefit) expense

$

(210

)

$

183

$

(393

)

(214.8

)%

AvePoint’s income tax benefit for the three months ended September 30, 2025 was $0.2 million, as compared to a tax expense of $0.2 million for the three months ended September 30, 2024. The effective tax rate was (1.6)% for the three months ended September 30, 2025, compared to 5.9% for the three months ended September 30, 2024. The change in effective tax rates was primarily due to the mix of pre-tax income (loss) results by jurisdictions taxed at different rates, certain jurisdictions with separate tax expense calculated, impact of foreign inclusions, stock-based compensation, and changes in valuation allowance.

In assessing the need for a valuation allowance, the Company has considered all available positive and negative evidence including its historical levels of income, expectations of future taxable income, future reversals of existing taxable temporary differences and ongoing tax planning strategies. If in the future, the Company determines it is more likely than not that deferred tax assets will not be realized, the Company may set up a valuation allowance, which may result in income tax expense in the Company’s condensed consolidated statements of income (loss) and condensed consolidated statements of comprehensive income (loss).

       38

       Part I

       Item 2

Comparison of Nine Months Ended September 30, 2025 and September 30, 2024

Revenue

The components of AvePoint’s revenue during the nine months ended September 30, 2025 and 2024 were as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Revenue:

SaaS

$

230,241

$

165,820

$

64,421

38.8

%

Term license and support

31,255

35,128

(3,873

)

(11.0

)%

Services

39,189

31,808

7,381

23.2

%

Maintenance

4,125

8,543

(4,418

)

(51.7

)%

Total revenue

$

304,810

$

241,299

$

63,511

26.3

%

Total revenue increased 26.3% to $304.8 million for the nine months ended September 30, 2025, primarily due to an increase in SaaS revenue, which increased 38.8% to $230.2 million, and represented 76% of total revenue, up from 69% of total revenue in the prior year. The increase in SaaS revenue, which was driven by strong customer demand for our SaaS solutions, was partially offset by an expected decrease in term license and support and maintenance revenues. The growth in total revenue was also due to an increase in services revenue, which grew 23.2% to $39.2 million.

Services revenue is expected to fluctuate as the services generally are not recurring in nature. Additionally, maintenance revenue is expected to continue declining as we have shifted away from the sale of perpetual licenses and towards SaaS and term licenses. Without perpetual license sales, there will be limited opportunities to sell maintenance contracts to new customers. Existing customers have and will continue to transition to SaaS and term licenses, which will continue the decline in maintenance revenue. 

Revenue by geographic region for the nine months ended September 30, 2025 and 2024 was as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

North America

$

119,117

$

99,240

$

19,877

20.0

%

EMEA

96,760

72,193

24,567

34.0

%

APAC

88,933

69,866

19,067

27.3

%

Total

$

304,810

$

241,299

$

63,511

26.3

%

For the nine months ended September 30, 2025, North America revenue increased 20.0% to $119.1 million, driven by a 35.1%, or $25.6 million, increase in SaaS revenue, partially offset by a combined $5.7 million net decrease in term license and support, services, and maintenance revenues. EMEA revenues increased 34.0% to $96.8 million, driven by a 42.7%, or $25.6 million, increase in SaaS revenue, partially offset by a combined $1.1 million net decrease in term license and support, services and maintenance revenues. APAC revenues increased 27.3% to $88.9 million, primarily driven by a 40.1%, or $13.2 million, increase in SaaS revenue, a 26.7%, or $6.8 million, increase in services revenue, and a combined $1.0 million net decrease in term license and support, and maintenance revenues. 

On a constant currency basis, EMEA revenues increased 30.1%, while EMEA SaaS revenues increased 38.4%. On a constant currency basis, APAC revenues increased 26.3%, while APAC SaaS revenues increased 40.0%.

       39

Table of Contents

       Part I

       Item 2

Non-GAAP Financial Measures

In addition to our financial results determined in accordance with GAAP, we disclose non-GAAP cost of revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP sales and marketing expense, non-GAAP general and administrative expense, non-GAAP research and development expense, non-GAAP operating income and non-GAAP operating margin.

We believe these non-GAAP measures aid investors by providing additional insight into our operational performance and into trends affecting our business. Management uses these non-GAAP financial measures to understand and compare operating results across accounting periods, for internal budgeting and forecasting purposes, and to evaluate financial performance.

Non-GAAP operating income and non-GAAP operating margin should not be considered as an alternative to operating income, operating margin or any other performance measures derived in accordance with GAAP as measures of performance. Non-GAAP operating income and non-GAAP operating margin should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP.

Cost of Revenue, Gross Profit, and Gross Margin

Cost of revenue, gross profit, and gross margin during the nine months ended September 30, 2025 and 2024 were as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Cost of revenue:

SaaS

$

41,156

$

30,139

$

11,017

36.6

%

Term license and support

1,074

1,202

(128

)

(10.6

)%

Services

35,973

28,777

7,196

25.0

%

Maintenance

320

487

(167

)

(34.3

)%

Total cost of revenue

$

78,523

$

60,605

$

17,918

29.6

%

Gross profit

226,287

180,694

45,593

25.2

%

Gross margin

74.2

%

74.9

%

—

—

GAAP cost of revenue

$

78,523

$

60,605

$

17,918

29.6

%

Stock-based compensation expense

(1,150

)

(1,516

)

366

(24.1

)%

Amortization of acquired intangible assets

(1,092

)

(722

)

(370

)

51.2

%

Non-GAAP cost of revenue

$

76,281

$

58,367

$

17,914

30.7

%

Non-GAAP gross profit

228,529

182,932

45,597

24.9

%

Non-GAAP gross margin

75.0

%

75.8

%

—

—

Cost of revenue increased 29.6% to $78.5 million for the nine months ended September 30, 2025, primarily driven by a $8.4 million increase from higher aggregate hosting costs resulting from increased SaaS revenue and a $7.4 million increase in personnel costs. 

       40

Table of Contents

       Part I

       Item 2

Operating Expenses 

Sales and Marketing

Sales and marketing expenses during the nine months ended September 30, 2025 and 2024 were as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Sales and marketing

$

105,888

$

90,459

$

15,429

17.1

%

Percentage of revenue

34.7

%

37.5

%

—

—

GAAP sales and marketing

$

105,888

$

90,459

$

15,429

17.1

%

Stock-based compensation expense

(7,847

)

(6,684

)

(1,163

)

17.4

%

Amortization of acquired intangible assets

(397

)

(342

)

(55

)

16.1

%

Non-GAAP sales and marketing

$

97,644

$

83,433

$

14,211

17.0

%

Non-GAAP percentage of revenue

32.0

%

34.6

%

—

—

Sales and marketing expenses increased 17.1% to $105.9 million for the nine months ended September 30, 2025, primarily driven by a $12.3 million increase in personnel costs, and a $1.9 million increase in marketing spend.

General and Administrative 

General and administrative expenses during the nine months ended September 30, 2025 and 2024 were as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

General and administrative

$

62,304

$

52,095

$

10,209

19.6

%

Percentage of revenue

20.4

%

21.6

%

—

—

GAAP general and administrative

$

62,304

$

52,095

$

10,209

19.6

%

Stock-based compensation expense

(15,849

)

(15,451

)

(398

)

2.6

%

Secondary listing costs

(2,941

)

—

(2,941

)

100.0

%

Discontinuation of growth equity fund

(1,917

)

—

(1,917

)

100.0

%

Non-GAAP general and administrative

$

41,597

$

36,644

$

4,953

13.5

%

Non-GAAP percentage of revenue

13.6

%

15.2

%

—

—

General and administrative expenses increased 19.6% to $62.3 million for the nine months ended September 30, 2025. The increase was primarily driven by a $5.3 million increase in personnel costs and $2.9 million of one-time costs related to the Company’s secondary listing on the SGX-ST, and $1.9 million of costs related to the discontinuation of the Company’s participation in the Fund. 

       41

Table of Contents

       Part I

       Item 2

Research and Development 

Research and development expenses during the nine months ended September 30, 2025 and 2024 were as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Research and development

$

39,585

$

35,827

$

3,758

10.5

%

Percentage of revenue

13.0

%

14.8

%

—

—

GAAP research and development

$

39,585

$

35,827

$

3,758

10.5

%

Stock-based compensation expense

(6,595

)

(6,156

)

(439

)

7.1

%

Non-GAAP research and development

$

32,990

$

29,671

$

3,319

11.2

%

Non-GAAP percentage of revenue

10.8

%

12.3

%

—

—

Research and development expenses increased 10.5%

to $39.6 

million for the 

   nine

 months ended 

   September 30, 2025

, primarily driven by a $2.6 million increase in personnel costs associated with the expansion of our workforce.

Income Tax Provision

Income tax expense during the nine months ended September 30, 2025 and 2024 was as follows:

Nine Months Ended

September 30,

Change

2025

2024

Amount

%

(in thousands, except percentages)

Income tax expense

$

5,058

$

6,170

$

(1,112

)

(18.0

)%

AvePoint’s income tax expense for the nine months ended September 30, 2025 was $5.1 million, compared to $6.2 million for the nine months ended September 30, 2024. The effective tax rate was 20.6% for the nine months ended September 30, 2025, compared to (106.5)% for the nine months ended September 30, 2024. The change in effective tax rates was primarily due to the mix of pre-tax income (loss) results by jurisdictions taxed at different rates, the impact of foreign inclusions, stock-based compensation, and changes in valuation allowance.

In assessing the need for a valuation allowance, the Company has considered all available positive and negative evidence including its historical levels of income, expectations of future taxable income, future reversals of existing taxable temporary differences and ongoing tax planning strategies. If in the future, the Company determines it is more likely than not that deferred tax assets will not be realized, the Company may set up a valuation allowance, which may result in income tax expense in the Company’s condensed consolidated statements of income (loss) and condensed consolidated statements of comprehensive income (loss).

       42

Table of Contents

       Part I

       Item 2

Non-GAAP Operating Income and Non-GAAP Operating Margin 

The following table presents a reconciliation of non-GAAP operating income from the most comparable GAAP measure, operating income, for the periods presented:

Three Months Ended

Nine Months Ended

September 30,

September 30,

2025

2024

2025

2024

(in thousands, except percentages)

GAAP operating income

$

8,129

$

7,652

$

18,510

$

2,313

GAAP operating margin

7.4

%

8.6

%

6.1

%

1.0

%

Add:

Stock-based compensation

10,678

9,811

31,441

29,807

Amortization of acquired intangible assets

477

362

1,489

1,064

Secondary listing costs

2,941

—

2,941

—

Discontinuation of growth equity fund

1,917

—

1,917

—

Non-GAAP operating income

$

24,142

$

17,825

$

56,298

$

33,184

Non-GAAP operating margin

22.0

%

20.1

%

18.5

%

13.8

%

Non-GAAP operating income and non-GAAP operating margin are non-GAAP financial measures that our management uses to assess our overall performance. We define non-GAAP operating income as GAAP operating income (loss) plus stock-based compensation and the amortization of acquired intangible assets and expenses related to the secondary listing on the SGX-ST and the discontinuation of the Company's participation in the Fund. We define non-GAAP operating margin as non-GAAP operating income divided by revenue. We believe non-GAAP operating income and non-GAAP operating margin provide our management and investors consistency and comparability with our past financial performance and facilitate period-to-period comparisons of operations, as these metrics eliminate the effects of stock-based compensation, which has had historical volatility from period to period due to mark-to-market securities, and of acquired intangible assets, which are unrelated to current operations and are neither comparable to the prior period nor predictive of future results. The elimination of the effect of variability caused by stock-based compensation expense and the amortization of acquired intangible assets, both of which are non-cash expenses, provides a better representation as to the overall operating performance of the Company. We use non-GAAP financial measures (a) to evaluate our historical and prospective financial performance and trends as well as our performance relative to our peers, (b) to set and approve spending budgets, (c) to allocate resources, (d) to measure operational profitability and the accuracy of forecasting, and (e) to assess financial discipline over operational expenditures.

GAAP operating margin for the three months ended September 30, 2025 and 2024 was 7.4% and 8.6%, respectively. Non-GAAP operating margin for the three months ended September 30, 2025 and 2024 was 22.0% and 20.1%, respectively. The increase in non-GAAP operating margin was primarily attributable to the Company’s enhanced focus on expense management and continued scaling of the Company’s channel partner strategy.

GAAP operating margin for the nine months ended September 30, 2025 and 2024 was 6.1% and 1.0%, respectively. Non-GAAP operating margin for the nine months ended September 30, 2025 and 2024 was 18.5% and 13.8%, respectively. The increase in non-GAAP operating margin was primarily attributable to the Company’s enhanced focus on expense management and continued scaling of the Company’s channel partner strategy.

Liquidity and Capital Resources 

As of September 30, 2025, we had $471.6 million in cash and cash equivalents and no outstanding debt.

Our short-term liquidity needs primarily include working capital for sales and marketing, research and development, and continued innovation. In addition, we extended a credit facility with a remaining commitment of $1.5 million, and committed $50.0 million to a growth equity fund. We also have letters of credit issued in the amount of $1.1 million as security for operating leases, and $5.8 million as security for customer contingency agreements. Our long-term capital requirements will depend on many factors, including our growth rate, levels of revenue, the expansion of sales and marketing activities, market acceptance of our platform, the results of business initiatives, and the timing of new product introductions. See “
Note 10 
–
 Commitments and Contingencies
” in Part I, Item 1 “
Financial Statements
” of this Quarterly Report on Form 10-Q for more information regarding the purchase commitments.

       43

Table of Contents

       Part I

       Item 2

We also maintain a loan and security agreement (the “
Loan Agreement
”), dated November 3, 2023, with HSBC Bank USA, National Association, (“
HSBC
”), as lender, for a revolving line of credit of up to $30.0 million with an accordion feature that provides up to $20.0 million of additional borrowing capacity we may draw upon at our request. The line bears interest at a rate equal to term SOFR plus 3.0% to 3.3% depending on the Consolidated Total Leverage Ratio (as defined in the Loan Agreement). The line carries an unused fee equal to 0.5%. The line will mature on November 3, 2026. We are required to maintain a minimum Consolidated Fixed Charge Coverage Ratio (as defined in the Loan Agreement) as well as a maximum Consolidated Total Leverage Ratio, tested by HSBC each quarter. Pursuant to the Loan Agreement, we pledged, assigned and granted HSBC a security interest in all shares of our subsidiaries, future proceeds, and assets as security for our obligations under the Loan Agreement. As of September 30, 2025, we are compliant with all covenants and had no borrowings outstanding under the Loan Agreement.

We believe that our existing cash and cash equivalents, our cash flows from operating activities, and our borrowing capacity under our Loan Agreement will be sufficient to meet our working capital and capital expenditure needs for at least the next twelve months. In the future, we may attempt to raise additional capital through equity or debt financing. The sale of additional equity would be dilutive to our stockholders. Additional debt financing could result in increased debt service obligations and more restrictive financial and operational covenants.

Cash Flows 

The following table sets forth a summary of AvePoint’s cash flows for the periods indicated.

Nine Months Ended

September 30,

2025

2024

(in thousands)

Net cash provided by operating activities

$

55,598

$

56,134

Net cash used in investing activities

(31,189

)

(1,369

)

Net cash provided by (used in) financing activities

155,456

(28,218

)

Operating Activities

Net cash provided by operating activities for the nine months ended September 30, 2025 was $55.6 million, reflecting AvePoint’s net income of $19.5 million, adjusted for non-cash items of $46.9 million and net cash outflows of $10.8 million from changes in operating assets and liabilities. The primary drivers of non-cash items were stock-based compensation and foreign currency remeasurement losses. The drivers of changes in operating assets and liabilities are seasonal in nature. These drivers are related to a decrease in accounts receivable due primarily to the timing of customer invoices, offset by an increase in prepaid expenses and other current assets primarily related to prepaid software maintenance and subscription, an increase in deferred revenue, offset by a decrease in accrued expenses primarily due to accrued bonuses, commissions and payroll taxes.

Net cash provided by operating activities for the nine months ended September 30, 2024 was $56.1 million, reflecting AvePoint’s net loss of $12.0 million, adjusted for non-cash items of $51.5 million and net cash inflows of $16.6 million from changes in operating assets and liabilities. The primary drivers of non-cash items were stock-based compensation and an increase in the mark to market value of earn-out and warranty liabilities. The drivers of changes in operating assets and liabilities are seasonal in nature. These drivers are related to a decrease in accounts receivable due primarily to timing of customer invoices and an increase in prepaid expenses and other current assets primarily related to prepaid software maintenance and subscription, an increase in deferred revenue and an increase in accrued expenses primarily due to income tax payable.

Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2025 was $31.2 million. It primarily consisted of $14.9 million of cash paid in business acquisitions, $12.1 million to repurchase the noncontrolling interest in MaivenPoint Pte. Ltd., $3.0 million of purchases of property and equipment, and $1.2 million from the capitalization of internal use software.

Net cash used in investing activities for the nine months ended September 30, 2024 was $1.4 million. It primarily consisted of $2.3 million of purchases of property and equipment, $1.5 million issuance of notes receivables, and $0.9 million from the capitalization of internal use software, offset by $3.5 million release of certificates of deposits that replaced by a sublimit of our line of credit. 

       44

Table of Contents

       Part I

       Item 2

Financing Activities

Net cash provided by financing activities for the nine months ended September 30, 2025 was $155.5 million, primarily consisting of $168.2 million of proceeds from the exercises of warrants, $8.5 million of proceeds from the exercise of stock options and $6.1 million of funds held on behalf of others, partially offset by $27.3 million in repurchases of common stock under the previously announced Share Repurchase Program that authorizes us to repurchase up to $150 million of our common shares (the “
Share Repurchase Program
”).

Net cash used in financing activities for the nine months ended September 30, 2024 was $28.2 million, primarily consisting of $21.7 million in repurchases of common stock under the Share Repurchase Program, $6.1 million in redemption of the redeemable noncontrolling interest of MaivenPoint, and $4.0 million in the purchase of our public warrants, partially offset by $3.6 million of proceeds from the exercise of stock options.

Indebtedness

Credit Facility

We maintain a line of credit under the Loan Agreement with HSBC, as lender. See “
Note 7

- Line of Credit
﻿” in Part I, Item 1 “
Financial Statements
” of this Quarterly Report on Form 10-Q.

The Loan Agreement provides for a revolving line of credit of up to $30.0 million and an additional $20.0 million accordion feature for additional capital we may draw upon at our request. Borrowings under the line currently bear interest at a rate equal to term SOFR plus 3.0% to 3.3% depending on the Consolidated Total Leverage Ratio (as defined in the Loan Agreement). The line carries an unused fee at a rate equal to 0.5%. Any proceeds of borrowings under the Loan Agreement will be used for general corporate purposes.

On a consolidated basis with our subsidiaries, we are required to maintain a minimum Consolidated Fixed Charge Coverage Ratio as well as a maximum Consolidated Total Leverage Ratio, tested by HSBC each quarter. Pursuant to the Loan Agreement, we pledged, assigned, and granted HSBC a security interest in all shares of our subsidiaries, future proceeds, and certain assets as security for our obligations under the Loan Agreement. Our line of credit under the Loan Agreement will mature on November 3, 2026.

To date, we are in compliance with all covenants under the Loan Agreement. We have not at any time borrowed under the Loan Agreement. The description of the Loan Agreement is qualified in its entirety by the full text of the form of such agreement, a copy of which is referenced as an exhibit to our Annual Report.

Leasing Activities

We are obligated under various non-cancelable operating leases for office space. The initial terms of the leases expire on various dates through 2030. As of September 30, 2025, the commitments related to these operating leases is $20.7 million, of which $8.4 million is due in the next twelve months.

Operating Segment Information

We operate in one segment. Our products and services are sold throughout the world, through direct and indirect sales channels. Our chief operating decision maker (the “
CODM
”) is our Chief Executive Officer. The CODM makes operating performance assessment and resource allocation decisions on a global basis. The CODM does not receive discrete financial information about asset allocation or profitability by product or geography. See the section titled “
Notes to Condensed Consolidated Financial Statements
” (Part I, Item 1 of this Quarterly Report) under the sub-heading “
Note 16 
–
 Segment Information
” for more information.

       45

Table of Contents

       Part I

       Item 2

Critical Accounting Policies and Estimates 

Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. We also make estimates and assumptions on the reported revenue generated and reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that our management believes are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

While our significant accounting policies are described in more detail in the section titled “
Notes to Condensed Consolidated Financial Statements
” (Part I, Item 1 of this Quarterly Report), we believe the following critical accounting policies and estimates are most important to understanding and evaluating our reported financial results.

Revenue Recognition

We derive revenue from four primary sources: SaaS, term license and support, services, and maintenance. Many of our contracts with customers include multiple performance obligations. Judgement is required in determining whether each performance obligation is distinct. Our products and services generally do not require a significant amount of integration or interdependency; therefore, our products and services are generally not combined. We allocate the transaction price for each contract to each performance obligation based on the relative standalone selling price (“
SSP
”) for each performance obligation within each contract.

We use judgment in determining the SSP for products and services. For substantially all performance obligations except term licenses, we are able to establish the SSP based on the observable prices of products or services sold separately in comparable circumstances to similar customers. We typically establish an SSP range for our products and services which is reassessed on a periodic basis or when facts and circumstances change. Term licenses are sold only as a bundled arrangement that includes the rights to a term license and support. In determining the SSP of license and support in a term license arrangement, we utilize observable inputs and consider the value relationship between support and term license when compared to the value relationship between support and perpetual licenses, the average economic life of our products, and software renewals rates. Using a combination of the relative fair value method, or the residual value method the SSP of the performance obligations in an arrangement is allocated to each performance obligation within a sales arrangement.

       46

Table of Contents

       Part I

       Item 2

Economic Conditions, Challenges, and Risks

The markets for software and cloud-based services are dynamic and highly competitive. Our competitors are developing new software while also deploying competing cloud-based services for consumers and businesses. Customer preferences evolve rapidly, and choices in hardware, products, and devices can and do influence how users access services in the cloud, and in some cases, the user’s choice of which suite of cloud-based services to use. We must continue to evolve and adapt to keep pace with this changing environment. The investments we are making in infrastructure, research and development, marketing, and geographic expansion will continue to increase our operating costs and may decrease our operating margins.

Our success is highly dependent on our ability to attract and retain qualified employees. We hire a mix of university and industry talent worldwide. We compete for talented individuals globally by offering an exceptional working environment, broad customer reach, scale in resources, the ability to grow one’s career across many different products and businesses, and competitive compensation and benefits.

Additionally, the demand for our software and services is correlated to global macroeconomic and geopolitical factors, which remain dynamic and where the outcomes and consequences are not possible to predict, and could materially adversely affect global trade, currency exchange rates, regional economies and the global economy. These in turn could increase our costs, disrupt our supply chain, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition, and results of operations.

Our international operations provide a significant portion of our total revenues and expenses. Many of these revenues and expenses are denominated in currencies other than the U.S. dollar. As a result, changes in foreign exchange rates may significantly affect revenue and expenses. Refer to the section titled “
Risk Factors
” (Part I, Item 1A of our Annual Report) for a discussion of these factors and other risks.

Seasonality

Our quarterly revenue fluctuates and does not necessarily grow sequentially when measuring any one fiscal quarter’s revenue against another. Historically, our first quarter has been our lowest revenue quarter and the fourth quarter has been our highest revenue quarter, however those results are not necessarily indicative of future quarterly revenue or full year results. Additionally, the timing of new product and service introductions can significantly impact revenue. Lastly, the mix of revenues in any given quarter can cause fluctuations in our reported results, due to differing revenue recognition principles.

Recently Issued and Adopted Accounting Pronouncements

For information about recent accounting pronouncements, see “
Note 2 - Summary of Significant Accounting

Policies
” in Part I, Item 1 “
Financial Statements
” of this Quarterly Report on Form 10-Q.﻿

       47

Table of Contents

Part I

Item 3

Item 3. Quantitative and Qualitative Disclosures About Market Risks 

Interest Rate Risk 

We had cash and cash equivalents, marketable securities, and short-term deposits of $472.0 million as of September 30, 2025, which we hold for working capital purposes. Our cash and cash equivalents are held in cash deposits and money market funds. Due to the short-term nature of these instruments, we do not believe that we have any material exposure to changes in the fair value of our investment portfolio due to changes in interest rates. Declines in interest rates, however, would reduce our future interest income. The effect of a hypothetical 10% change in interest rates would not have a material negative impact on our condensed consolidated financial statements. As of September 30, 2025, we had no outstanding obligations under our line of credit with HSBC under the Loan Agreement. To the extent we enter into other long-term debt arrangements in the future, we would be subject to fluctuations in interest rates which could have a material impact on our future financial condition and results of operation.

Foreign Currency Exchange Risk 

We have foreign currency risks related to our revenue denominated in currencies other than the U.S. Dollar, primarily consisting of the Euro, the Singapore Dollar, the Japanese Yen, the Australian Dollar and the British Pound Sterling. Our revenues therefore benefit from a weakening of the U.S. Dollar relative to these currencies and, conversely, are adversely affected by a strengthening of the U.S. Dollar relative to these currencies.

We also have foreign currency risks related to operating expenses denominated in a number of currencies other than the U.S. Dollar. Our expenses are therefore adversely affected from a weakening of the U.S. Dollar relative to these currencies and, conversely, benefit by a strengthening of the U.S. Dollar relative to these currencies. 

Revenues denominated in the U.S. Dollar as a percentage of total revenues were approximately 36% for the three months ended September 30, 2025. Expenses denominated in the U.S. Dollar as a percentage of total expenses were approximately 52% for the three months ended September 30, 2025.

A hypothetical 10% increase in the U.S. Dollar against other currencies would have resulted in a decrease in income from operations of approximately $2.1 million for the three months ended September 30, 2025. This analysis disregards that rates can move in opposite directions and that losses from one geographic area may be offset by gains from another geographic area. 

Concentration of Credit Risk 

We deposit our cash with financial institutions, and, at times, such balances may exceed federally insured limits.

       48

Table of Contents

Part I

Item 4

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer (in his capacity as “
Principal Executive Officer
”) and our Chief Financial Officer (in his capacity as “
Principal Financial and Accounting Officer
”), we conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e)) under the Exchange Act, as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Principal Executive Officer and Principal Financial and Accounting Officer concluded that our disclosure controls and procedures were effective as of September 30, 2025.

As such, our Principal Executive Officer and Principal Financial and Accounting Officer have concluded that our condensed consolidated financial statements included in this report present fairly, in all material respects, our financial position, results of operations, and cash flows for the periods presented in conformity with U.S. generally accepted accounting principles (“
GAAP
”).

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

       49

Table of Contents

Part II

Items 1 and 1A

PART

II.

OTHER INFORMATION

Item

1. 
Legal Proceedings

In the normal course of our business, we may be involved in various claims, negotiations, and legal actions. Except for such claims that arise in the normal course of business, as of and for the fiscal quarter ended September 30, 2025, we are not a party to any material asserted, ongoing, threatened, or pending claims, suits, assessments, proceedings, or other litigation.

Refer to the information under the section titled “
Risk Factors
” of our Annual Report (Part I, Item 1A of our Annual Report) for information regarding the potential legal and regulatory risks (including potential legal proceedings and litigation) in which we may become involved.

Item 1A. Risk Factors

Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, “
Risk Factors
” in our Annual Report and Part II, Item 1A “
Risk Factors
” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (“
Q1 2025 10-Q
”
),
 which risks and uncertainties could affect our business, financial condition, results of operations, cash flows, and the trading price of our common stock. Other than the risk factor set below, there have been no material changes to the risk factors previously disclosed in our Annual Report and Q1 2025 10-Q. We urge you to read the risk factors in our Annual Report and Q1 2025 10-Q.

Transfer between our common stock traded on the SGX-ST and our common stock traded on Nasdaq may adversely affect the liquidity and/or trading price of each other.

Our common stock is currently traded on Nasdaq and the SGX-ST. Subject to compliance with U.S. securities laws and procedures of The Central Depository (Pte) Limited (“
CDP
”) holders of our common stock may use CDP’s procedures for cross border securities transfers via The Depository Trust Company to transfer common stock traded on the SGX-ST to Nasdaq. Any holder of common stock traded on Nasdaq may also transfer such interests for trading on the SGX-ST. In the event that a substantial number of shares of common stock are exchanged, the liquidity and trading price of our common stock on the SGX-ST and common stock on Nasdaq may be adversely affected.

The time required for the transfer between our common stock traded on the SGX-ST and our common stock traded on Nasdaq might be longer than expected and investors might not be able to settle or effect any sale of their securities during this period, and the transfer involves costs. 

There is no direct trading or settlement between Nasdaq and the SGX-ST. CDP both acts as central depositary for the SGX-ST and is a DTC participant and facilitates settlement between the two markets via its procedures for cross border securities transfers via DTC. In addition, the time differences between Singapore and New York, unforeseen market circumstances, temporary closure of the facilities offered by CDP for cross border securities transfers via DTC, the procedures of a stockholder’s brokers in Singapore and/or the United States or other factors may delay the transfer of common stock from trading on the SGX-ST to Nasdaq (and vice versa). Investors will be prevented from settling or effecting the sale of their securities during such periods of delay. In addition, there is no assurance that any transfer of common stock from trading on the SGX-ST to Nasdaq (and vice versa) will be completed in accordance with the timelines that stockholders may anticipate. Furthermore, CDP and other DTC participants are entitled to charge holders fees for cross border securities transfers via DTC. Brokers in Singapore and/or the United States may charge additional fees. As a result, stockholders who transfer common stock from trading on the SGX-ST to Nasdaq (and vice versa) may not achieve the level of economic return the stockholders may anticipate. 

       50

Table of Contents

Part II

Items 2, 3 and 4

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES

During the three months ended September 30, 2025, we did not issue any shares of our common stock or any other equity securities without registration under the Securities Act of 1933, as amended.

Issuer Purchases of Equity Securities

On March 17, 2022, we announced that our Board of Directors authorized the Share Repurchase Program for us to buy back shares of our common stock for a period of three years from the date of authorization. On February 25, 2025, the Company’s Board of Directors renewed the Share Repurchase Program for an additional three years from the date of renewal. Under the Share Repurchase Program, we have the authority to buy up to $150 million of our common stock shares via acquisitions in the open market or privately negotiated transactions. Purchases made pursuant to the Share Repurchase Program may be conducted in compliance with Exchange Act Rule 10b-18 and/or Exchange Act Rule 10b5-1. Purchases made pursuant to the Share Repurchase Program will be conducted in compliance with all applicable legal, regulatory, and internal policy requirements, including our Insider Trading Policy. We are not obligated to make purchases of, nor are we obligated to acquire any particular amount of, our common stock under the Share Repurchase Program. The Share Repurchase Program may be suspended or discontinued at any time.

The following table presents information with respect to common stock shares repurchased under the Share Repurchase Program during the three months ended September 30, 2025:

Period

Total number of shares purchased
(1)

Average price paid per share
(2)

Total number of shares purchased as part of the Share Repurchase Program

Approximate dollar value of shares that may yet be purchased under the Share Repurchase Program
(3)

July 1, 2025 - July 31, 2025

2,691

$18.6061

2,691

$131,270,205

August 1, 2025 - August 31, 2025

136,492

$15.4363

136,492

$129,163,274

September 1, 2025 - September 30, 2025

388,949

$15.9360

388,949

$122,964,981

(1) All shares reported herein, including shares repurchased to satisfy employee taxes on vesting RSUs, were purchased pursuant to the publicly announced Share Repurchase Program.

(2) Average price paid per share includes costs associated with the repurchases and excludes the 1% excise tax on stock repurchases enacted by the Inflation Reduction Act of 2022.

(3) The maximum remaining dollar value of shares that may yet be purchased under the Share Repurchase Program is reduced by the aggregate price paid for share purchases in addition to any fees, commissions, or other costs that may arise as a result of the purchase.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

       51

Table of Contents

Part II

Item 5

ITEM 
5.
 OTHER INFORMATION

Rule 
10b5
-
1
 Plan Election

During the quarter ended 
 September 30, 2025, 
no
 director or officer of the Company, adopted or terminated a “Rule 
10b5
-
1
 trading arrangement,” or “non-Rule 
10b5
-
1
 trading arrangement,” as each term is defined in Item 
408
(a) of Regulation S-K. 

       52

Table of Contents

Part II

Item 6

Item

6. 
Exhibits

The following exhibits are filed as part of, furnished with, or incorporated by reference into, this Quarterly Report on Form 10-Q, in each case as indicated therein.

Exhibit

Index

Incorporated by Reference

Exhibit

Number

Description

Schedule/

Form

File No.

Exhibit

Filing Date

Filed Herewith

31.1

Certification of Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

X

31.2

Certification of Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

X

32.1**

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

X

32.2**

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

X

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

X

101.SCH

Inline XBRL Taxonomy Extension Schema Document.

X

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

X

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document.

X

101.LAB

Inline XBRL Taxonomy Extension Labels Linkbase Document.

X

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

X

104.1

Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101).

X

**

Furnished herewith. Any exhibit furnished herewith (including the certifications furnished in Exhibit 32.1 and Exhibit 32.2 hereto) are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.

       53

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AVEPOINT, INC.

Date: November 6, 2025

/s/ Tianyi Jiang

Name:

Tianyi Jiang

Title:

Chief Executive Officer

(Principal Executive Officer)

Date: November 6, 2025

/s/ James Caci

Name:

James Caci

Title:

Chief Financial Officer

(Principal Financial and Accounting Officer)

       54